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Embolic material from atherosclerotic lesions in the carotid arteries is one of the 
main aetiological factors for ischaemic stroke. According to a large body of evidence, 
carotid endarterectomy (CEA) can prevent strokes, provided that appropriate inclu-
sion criteria and high-quality perioperative treatment methods are utilised with low 
complication rates. From the patient’s perspective, it is of paramount importance 
that the operation is as safe and effective as possible. From the community’s point 
of view, it is important that CEA provision prevents as many strokes as possible.
In order to define the stroke preventing potential of CEA in different communi-
ties, a comparison between eight European countries and Australia was performed. 
A more detailed evaluation was performed in Finland, the United Kingdom and 
Egypt. It could be estimated that many potentially preventable strokes occur due 
to insufficient diagnostics and CEA provision. The number of CEAs should be at 
least doubled in Finland and the United Kingdom. 
Clinical registries provide a possibility to monitor and analyse large amounts of 
patients and treatment episodes. The validity of registered data is crucial, because 
major health care planning and resource allocation decisions are often based on 
registered data. All CEA patients were identified from the local vascular registry 
of Helsinki University Central Hospital (HUCH) and HUCH discharge registry. 
The material was cross-matched on an individual patient level. A simplified search 
strategy led to a possibility of severe misinterpretation. The initial search provided 
675 and 681 patients from the two different registries, but only 640 patients were 
included in both registries. Manual verification of the dataset revealed that 673 true 
CEAs had been performed from 2000 to 2005. The combined perioperative major 
morbidity and mortality (M&M) rate was 2.7%, corresponding well with earlier pub-
lished data and international recommendations. There was no systematic avoidance 
of complications, and comparable M&M rates were obtained from both registers 
irrespective of the level of verification. Accordingly, both registers can be used in 
planning the CEA provision, provided that regular registry audits are performed.
Time delay from symptom to surgery (symptom to knife time, i.e. SKT) has 
been identified as one of the most important factors influencing the effectiveness 
of carotid interventions. One hundred consecutive symptomatic patients who had 
CEA were identified from routine clinical practice in HUCH. Referral and diagnostic 
pathways were analysed. SKT was calculated for each patient and divided into pa-
tient related, referral related, diagnostics related and operation queue related delays 
in order to identify the reasons for prolonged SKTs.  The median SKT was 47 days 
(range 3–688 d.), which is far longer than the recommended 14 days. Only 11% of 
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the patients were operated on within 2 weeks. The patients had a higher likelihood 
of reaching the target time if they were immediately referred to the same centre 
where the operation took place (OR 12.6, 95% CI 1.5–104, p=0.019). In conclusion, 
the primary diagnostic investigations for stroke, transient ischaemic attack (TIA) 
and amaurosis fugax patients should be performed on an emergency basis to reach 
the recommended SKT.
A total of 53,077 carotid procedures between 2005 and 2010 were registered in 
nine countries as part of the VASCUNET collaboration. There were clear differen-
ces in the theoretical stroke prevention effectiveness of CEA provision between the 
participating countries. 92.6% of the CEAs were performed according to European 
guideline recommendations. The proportion of patients who were operated on in a 
situation where no theoretical benefit to the patient could be expected varied from 
nil to 29.7% between the countries. The utility rate (N of interventions) of carotid 
procedures in one year per 100,000 inhabitants varied from 6.0 to 13.5 for all pa-
tients, and from 3.6 to 11.1 for symptomatic patients, revealing that there are major 
differences in the diagnostic and treatment processes of care between the countries. 
The reasons for these differences should be identified in order to be able to prevent 
more strokes. Carotid surgery was performed safely in all participating countries. 
A previously unpublished method of combining medial mandibulotomy, neck 
incision and carotid artery interposition was carried out as a collaboration of ma-
xillofacial, ear, nose and throat and vascular surgeons. Five patients were operated 
on with a technique that was feasible and possible to perform with little morbidi-
ty, but due to the significant risks involved, this technique should be reserved for 
carefully selected cases.  
In stroke prevention, organisational decisions seem far more important than 
details in interventional procedures when surgery is carried out with low compli-
cation rates, as was the case in the present study. A TIA clinic approach with close 
co-operation between the on-call vascular surgeons, neurologists and radiologists 
should be available at all centres treating these patients. Patients should have a 




Carotid endarterectomy (CEA) for stroke prevention is probably the most stand-
ardised operation in vascular surgery. There are few other fields of surgery where 
decision-making is supported by so many randomised clinical trials (RCT). One of 
the main reasons for stroke is flow disturbance caused by embolism from an athero-
sclerotic lesion in the extracranial vessels, mainly in the internal carotid artery (ICA). 
RCTs, meta-analyses and guidelines have given the indications and limitations for 
CEA in many but not all clinical situations. The outcomes of RCTs can only partly 
be achieved in a community-wide clinical practice. The nature of CEA is preven-
tive, and thus many of the operations performed do not actually help the patient 
operated on, although the CEA could statistically and clinically be well justified. It 
is not the case that all operated patients would eventually have suffered a stroke 
if they had not been operated on. However, all surgically treated patients face the 
risks of surgery. Therefore, physicians treating carotid atherosclerosis should be 
aware of their own results and the results of a large number of studies, use scientific 
data in daily decision-making and follow the national and international guidelines 
in their clinical practice. 
Stroke is predominantly a disease of the elderly. The population of Finland and 
many other developed countries is aging fast, and stroke and its complications 
are getting more frequent despite the declining age-specific incidence and more 
effective treatment methods (Sivenius et al. 2010). During the past four decades, 
high-income countries have observed a worldwide 42% decrease in stroke incidence 
whereas the incidence in low to middle income countries has increased by more 
than 100% (Feigin et al. 2009). Modern cholesterol-lowering drugs (Cholesterol 
Treatment Trialists’ (CTT) Collaborators 2005), antiplatelet treatments (Lemmens 
et al. 2009) and blood pressure lowering medications  (Law et al. 2009) have 
reduced the incidence of stroke and may stabilise the plaque itself, but good me-
dical care does not abolish the need of carotid surgery (Sillesen 2008; Lutz et al. 
2011). At the same time, resources are getting scarcer, hospital administrations are 
getting more complex, centralisation is seen as a solution (Kantonen et al. 1998, 
Holt et al.  2007, Nazarian et al. 2008), and the workload of individual surgeons is 
restricted by legal working time limitations (Fletcher et al.  2005). Due to all these 
reasons, focus should be kept on the question of finding the most effective ways 
to prevent strokes. Invasive treatment should be preserved for those patients who 
are at a high risk of stroke. The benefits and risks of an invasive approach should 
be objectively evaluated for the benefit of the individual patient – not the surgeon 
or interventionalist (Naylor et al. 2009). It seems that the differences found in 
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randomised studies are far smaller than the importance of effective organisations 
with short delays and the actual application of the results of RCTs in daily clinical 
praxis (Bunch and Kresowik 2004, Ploeg et al. 2010).
In addition to atherosclerosis, the carotid arteries may be affected by some 
other diseases, such as dissections, inflammation, genetic disorders, tumours and 
aneurysms (Nair et al. 2000; Sajid et al. 2007).  For malignant tumours, the only 
curative treatment opportunity may be an operation in which all tumour material 
is excised (Wright et al.1996). Thus, extensive and potentially mutilating surgery is 
sometimes needed, but it should be practiced with great caution and only at spe-
cialised clinics. Extensive aneurysms and trauma to the carotid arteries may also 
need special surgical and/or endovascular techniques. 
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reVieW oF tHe Literature
1. diseases aFFeCting tHe Carotid arteries
1.1. Atherosclerosis And stroke
Atherosclerosis is a disease affecting arterial blood vessels. It is a chronic inflamma-
tory response in the walls of arteries which is in large part due to the accumulation 
of macrophage white blood cells promoted by oxygenated low-density lipoproteins. 
The aetiology and pathogenesis of atherosclerosis are complex. Vigorous research 
to clarify the importance and relations of different genetic, behavioural and envi-
ronmental risk factors has been ongoing for decades. Dyslipidemia, hypertension, 
smoking and diabetes are classic risk factors, but they are not sufficient to explain 
the development of atherosclerosis. Inflammatory mechanisms play a key role in 
all stages of atherosclerosis—from the initial formation of “fatty streaks” to plaque 
rupture, causing clinical events (i.e., myocardial infarct, stroke, or leg ischaemia 
(Ross 1999; Lusis 2000). Chronic infections, such as Chlamydia pneumoniae infec-
tions, have been implicated in the pathogenesis of atherosclerosis as one possible 
mechanism for induction of inflammation, but these theories remain controversial. 
(Saikku et al. 1988; Fazio et al. 2009; Vikatmaa et al. 2010). It is not well known why 
some individuals develop problems in their coronary arteries that lead to myocardial 
issues; for some patients, the vessels supplying the brain are affected, which causes 
stroke, while other patients develop walking disturbances or need an amputation 
due to atherosclerotic changes in their lower extremity arteries. It is also not known 
why the most important risk factor for coronary disease is hypercholesterolemia, 
while for stroke it is hypertension, and for lower extremity arteries it is smoking, as 
each of the three is a risk factor for all three vascular beds. Other sites may also be 
affected, but the three aforementioned are the most frequent ones. The CAPRIE trial 
(clopidogrel versus aspirin in patients at risk of ischaemic events) enrolled 19,185 
patients with established peripheral arterial disease (PAD), a recent myocardial 
infarction or recent ischaemic stroke in approximately equal distribution. However, 
based on the baseline characteristics of these patients, many of them already had 
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a prior history of ischaemic events in more than one vascular bed. Thus, at study 
entry, ~26% of the patients had ischaemic vascular disease in at least two vascular 
beds, demonstrating the generalised nature of atherothrombosis (CAPRIE steering 
committee 1996).
Each year 15 million people worldwide experience an acute stroke of either 
ischaemic or hemorrhagic aetiology. One third will die secondary to their stroke, 
while another third experience a permanent disability (Feigin et al. 2009). In Fin-
land, 14,600 persons had a stroke in 2007, and as some suffered a recurrent stroke 
during the same year, the total annual rate of stroke was 17,100 (Working group 
appointed by The Finnish Medical Society Duodecim and Finnish Neurological 
Society, 2011). The incidence of stroke declined from the beginning of 1970 to late 
1990 by around 30% in men and by 25% in women. The mortality declined by 60 
% in men and by 55% in women during the same time period (Numminen et al. 
1996). It has been estimated that if this favourable trend continues, the burden 
of stroke will not increase substantially in spite of the increasing ratio of elderly 
people in the Finnish population, but if this development does not continue, there 
will be over 20,000 first-ever strokes in Finland in 2030 (Sivenius et al. 2009). 
Atherosclerosis in extra- or intracranial arteries may cause flow disturbances and 
stroke. 67.3–80.5% of strokes were classified as ischaemic in an overview of popu-
lation-based epidemiological studies by Feigin et al. (Feigin et al. 2003). Carotid 
artery stenosis is responsible for 10–16% of all strokes (Poisson and Johnston 2011). 
30–40% of ischaemic strokes are preceded by a transient ischaemic attack (TIA), 
amaurosis fugax (AFX) or a minor stroke, providing a window of opportunity for 
stroke prevention (Rothwell et al. 2006).
1.2. MAnifestAtions of cArotid Artery  
Atherosclerotic diseAse
1.2.1. AsyMptoMAtic Atherosclerotic stenosis
It is not uncommon that an asymptomatic stenosis of the ICA is found in clini-
cal examination or in the ultrasound examination of the neck. Many neurological 
symptoms are unspecific, and as the scientific data to support CEA for symptomatic 
carotid disease is based on RCTs with strict symptom-specific inclusion criteria, 
the patients with miscellaneous unspecific symptoms should not be classified as 
symptomatic in the surgical context. Silent infarcts that may be seen in computed 
tomography (CT) scan or magnetic resonance imaging (MRI), but which have not 
caused clinical symptoms, should also be classified as asymptomatic in this context. 
However, it is obvious that patients with such silent lesions will be considered for 
16
Review of the literature
CEA by the clinician with special attention (Coccheri 2004; Henriksson et al. 2008).
An asymptomatic atherosclerotic lesion in the carotid bifurcation carries a risk 
of ipsilateral stroke of 2% or less per year. It has turned out to be difficult to predict 
which lesions will cause complications and which will remain asymptomatic (MRC 
Asymptomatic Carotid Surgery Trial (ACST) Collaborative Group 2004; Abbott et al. 
2007). The ACSRS (Asymptomatic Carotid Stenosis and Risk of Stroke Study) was 
a multicentre prospective trial, which stratified the risk of future stroke according to 
clinical and ultrasound criteria in 1,121 patients with carotid artery stenosis. Grade 
of stenosis, history of contralateral TIAs or stroke, low echodensity (gray scale me-
dia), plaque area and discrete white areas (DWAs) without acoustic shadowing were 
independent predictors of ipsilateral cerebrovascular or retinal ischaemic (CORI) 
events (Nicolaides et al. 2010). 
1.2.2. WArning signs: AMAurosis fugAx (Afx), trAnsient ischAeMic  
AttAck (tiA) And Minor stroke
If a carotid lesion sends an embolus, it may cause different symptoms depending 
on the artery it occludes. All neurological, potentially ischaemic symptoms should 
be evaluated on an emergency basis (Lavallée et al. 2007, Rothwell et al. 2007, 
Luengo-Fernandez et al. 2009).
The ophthalmic artery is the first branch from the ICA, and it is not uncom-
mon that small debris from an ICA lesion to retinal arteries causes an ipsilateral 
monocular transient ischaemic attack causing visual loss, a phenomenon called 
amaurosis fugax. Typically, the patient describes total or subtotal transient blind-
ness or a “curtain” in one eye. The attacks are repetitive in nature, and the patients 
may describe that they have had these symptoms for months or years. Ischaemic 
blindness may follow from persistent ophthalmic artery occlusion (Benavente et al. 
2001; Cohen et al. 2010). In the North American Symptomatic Carotid Endarterec-
tomy Trial (NASCET), the medically treated patients with AFX and a high-grade 
carotid stenosis had a 16.6% +/- 5.6% (2SD) risk of ipsilateral stroke at 2 years 
(North American Symptomatic Carotid Endarterectomy Trial Collaborators 1991; 
Streifler et al. 1995; Mead et al. 2002). 
A somewhat larger embolus may find its way to larger intracranial arteries and 
different areas of the brain and cause either transient or permanent cerebral ischa-
emia. One way to differentiate a TIA from a minor stroke is that after a TIA, there is 
no brain tissue death, and brain scanning is negative, whereas a permanent cerebral 
lesion may be seen after a stroke. As the imaging methods have improved over time 
and even very small flow disturbances with permanent brain lesion may be seen 
in advanced imaging, it has become somewhat difficult to distinguish a TIA from 
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a minor stroke (Pavlovic et al. 2010). The most typical TIA symptoms are cont-
ralateral limb weakness, which affect the upper limb more severely, contralateral 
facial palsy and speech disturbances. In NASCET, the 2-year risk of stroke after a 
hemispheric TIA for patients with a high grade carotid artery stenosis was 43.5% 
+/- 6.7% (Streifler et al. 1995). Stroke may present soon after a TIA. A half of the 
strokes that occur within 3 months after a TIA occur within 48 hour from the in-
dex TIA (Johnston et al. 2000). Therefore, these symptoms should lead to prompt 
examinations and treatment (Daffertshofer et al. 2004; Rothwell et al. 2006).
1.2.3. MAjor stroke
The first symptom caused by a carotid lesion may be a permanent major stroke 
leading to severe disability or death. The symptoms and the prognosis of the pa-
tient depend on the area and the size of the cerebral infarct. Emergent evaluation 
and treatment within minutes or hours of symptom onset have proven effective in 
diminishing the injury and improving the prognosis of the patient (Wardlaw et al. 
2009). Early revascularisation may save tissue in the area of ischaemic penumbra 
(Goldemund and Mikulik 2010). Returning the blood flow to the ischaemic brain 
cortex causes a potentially dangerous reperfusion injury with a risk of subsequent 
cerebral haemorrhage. One of the key questions in effective carotid surgery is the 
timing of the operation after a stroke (Rerkasem and Rothwell 2009a). If the time 
between the stroke and the operation is too short, and the ischaemic brain area is 
signifcant, the reperfusion damage may cause further neurological problems or even 
death. However, sometimes a second or repetitive embolus may cause permanent 
damage that could have been avoided by early CEA. An acute occlusion of the ICA 
and potentially salvageable brain tissue can be identified on MRI, and an emergent 
operation may be justified (Paty et al. 2003, Weis-Müller et al. 2008). However, an 
acute MCA occlusion is more frequent and intravascular therapies are used more 
often than emergency surgery in acute MCA occlusion. Intra-arterial mechanical 
thrombectomy, either alone or combined with thrombolysis, is quite widely used, 
especially in the USA, although it is not yet supported by RCTs (Alexandrov 2010). 
The National Institute of Health Stroke Scale (NIHSS) is widely used in clinical trials 
and daily practice in the evaluation of the severity of acute stroke (Table 1) (Lyden 
et al. 1994), while the modified Rankin Scale score (mRS) is a widely used method 
to estimate the outcome of stroke (van Swieten et al. 1988) (Table 2). 
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table 1. the national Institute of Health Stroke Scale (nIHSS) used in the estimation of the 
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2 = not alert, obtunded
3 = Unresponsive
0 = Answers both questions correctly
1 = Answers one question correctly
2 = Answers neither question correctly
0 = Performs tasks correctly
1 = Performs one task correctly
2 = Performs neither task
0 = normal
1 = Partial gaze palsy
2 = total gaze palsy
0 = no visual loss
1 = Partial hemianopsia
2 = Complete hemianopsia
3 = Bilateral hemianopsia
0 = normal
1 = Minor paralysis
2 = Partial paralysis
3 = Complete paralysis
0 = no drift
1 = Drift before 10 seconds
2 = Falls before 10 seconds
3 = no efforts against gravity
4 = no movement
0 = no drift
1 = Drift before 5 seconds
2 = Falls before 5 seconds
3 = no efforts against gravity
4 = no movement
0 = Absent
1 = one limb
2 = two limbs
0 = normal
1 = Mild loss
2 = Severe loss
0 = normal
1 = Mild aphasia
2 = Severe aphasia
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table 2. Modified rankin Scale (mrS) for the estimation of the degree of stroke severity 
(van Swieten et al. 1988).
Grade Description
0 no symptoms at all
1 no significant disability despite symptoms: able to carry out all usual duties 
and activities
2 Slight disability: unable to carry out all previous activities but able to look 
after own affairs without assistance
3 Moderate disability: requires some help, but able to walk without assistance
4 Moderately severe disability: unable to walk without assistance and unable to 
attend to own bodily needs without assistance
5 Severe disability: bedridden, incontinent, and requiring constant nursing care 
and attention
1.2.4. crescendo tiA, stroke in evolution, floAting throMbus And 
Acute occlusion
Crescendo TIA (TIA attacks occurring with increasing frequency and/or severity) 
or a stroke with progressing symptoms in an acute setting should be distinguished 
from a single TIA or minor stroke, as these situations are thought to carry an ex-
tremely high risk of recurrent embolism and severe stroke, if left untreated, and 
they also carry a high risk after CEA (20.2% (CI 12.0–28.4) for stroke in evolution 
and 11.4% (CI 6.1–16.7) after crescendo TIA) (Rerkasem and Rothwell 2009a). At 
times, a free-floating thrombus or acute occlusion may be seen at the ICA stenosis, 
and an emergent operation may be justified after careful consideration (Paty et al. 
2003; Bhatti et al. 2007; Weis-Müller et al. 2008).
1.2.5. hypoperfusion And oculAr ischAeMic syndroMe 
A severe unilateral or, most often, bilateral carotid and/or vertebral artery stenosis 
or occlusion may cause hypoperfusion to the brain, especially when the general 
blood pressure is low or transiently reduced, e.g. in case of severe aortic stenosis, 
arrhythmias or orthostatic hypotension. The typical complaint is dizziness or syn-
cope, and the patients learn to sit and wait for some time before standing up. If the 
symptom is severe, CEA or bypass may be justified. However, it has to be remem-
bered that, upon opening the stenosis, the risk of too high a flow (hyperperfusion) 
to the ischaemic brain is high, and caution in patient selection and perioperative 
care should therefore be administered (Russell and Gough 2004; Nouraei  et al. 
2005; Stoneham and Thompson 2009).
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OIS is a chronic condition that most commonly results from severe carotid artery 
stenosis (≥90%), with a 5-year mortality rate of about 40%. Carotid artery stenosis 
compromises laminar retinal artery flow and results in disturbed flow patterns, 
hypoperfusion, hypoxia, and ischaemia of highly metabolic retinal tissues. OIS is 
associated with carotid artery stenosis from 20% to 100% in the reported series 
(Cohen et al. 2010). However, there is insufficient evidence to draw conclusions 
about whether surgery is beneficial in these cases or not (Wolintz 2005).
1.3. other diseAses Affecting the cArotid Arteries
1.3.1. AneurysMs 
Extracranial carotid arteries are a rare location for aneurysmal disease. Thus, the 
evidence to support the decision of when to operate is scarce. The feared complica-
tion is usually not rupture, but rather embolism and stroke. Occasionally, a large 
aneurysm may cause symptoms attributable to the compression of the adjacent cra-
nial nerves (e.g. Horner’s syndrome) or other compression symptoms like discom-
fort, pain or dysphagia. It is generally accepted that most aneurysms of the carotid 
arteries should be considered for surgical or endovascular treatment (Coffin et al. 
1997; Hertzer 2000; Attigah et al. 2009). It seems that at least the ICA aneurysms 
often cause tortuosity that may limit endovascular treatment possibilities. On the 
other hand, exposure of the high ICA or low common carotid artery (CCA) may be 
extensive and cause morbidity, and thus steer the decision towards conservative 
treatment and follow-up (Longo and Kibbe 2005). When feasible, endovascular 
treatment has a high procedural success rate (Li et al 2009).
1.3.2. tuMours
The tissue around the carotid sheath is rich in lymphatic tissue and lymphatic 
nodes. Therefore, malignant head and neck tumours may either directly infiltrate 
the carotid artery or send metastatic tumours that grow around the carotid arter-
ies. Paragangliomas of the carotid bifurcation, called carotid body tumours (CBTs), 
originate from the blood pressure regulating tissue in the carotid bifurcation. CBTs 
are typically benign but they may occasionally present with malignant characteris-
tics. The carotid body is well supplied with small vessels directly from the carotid 
artery, and thus the tumours are rich in vasculature and attached to the carotid 
bifurcation (Boedeker et al. 2005). Malignant head and neck tumour invasion of the 
carotid arteries may be surgically challenging, and tumours involving the distal ICA 
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are often considered inoperable. Radical tumour excision is, on the other hand, the 
only curative treatment for malignant neck tumours and may also be considered in 
selected cases in spite of arterial invasion. Carotid interposition is a method which is 
in routine use in vascular surgery and which may be performed with minor added 
morbidity. Therefore, it seems obvious that in some cases carotid artery resection 
and interposition should be performed instead of taking a risk of incomplete tumour 
resection (McCready et al. 1989; Wright et al. 1996; Muhm et al. 2002).
1.3.3. fibroMusculAr dysplAsiA (fMd)
FMD is a rare nonatheromatous arterial disease of unknown aetiology, most com-
monly affecting the renal or internal carotid arteries. Occasionally, a secondary 
complication of carotid FMD may lead to embolic neurological events, carotid dis-
section or aneurysmal dilatation. In addition to antiplatelet therapy, angioplasty 
of the diseased segment may be indicated. Rare cases of symptomatic complicated 
carotid artery FMD have been operated by open resection and vein graft interposi-
tion (Olin and Sealove 2011).
1.3.4. cArotid Artery dissection
Either spontaneous or traumatic carotid artery dissections are estimated to account 
for 2% of all ischaemic strokes. However, they account for approximately 20% of 
strokes in patients less than 45 years of age. A pre-existing atheromatous or, for 
example, FMD lesion may or may not be identified as the entry site for dissection. 
Carotid dissection can cause ischaemic stroke either by thromboembolic mechanism 
or as a result of haemodynamic insufficiency due to severe stenosis or occlusion. 
Late complications include carotid stenosis with haemodynamic insufficiency and 
aneurysmal dilatation. Anticoagulation followed by antiplatelet therapy is the most 
commonly recommended treatment. Most commonly, aneurysms remain asymp-
tomatic and may be followed up, but in rare cases, dilatation may justify open or 
endovascular repair (Redekop 2008). Both traumatic and spontaneous dissections 
have been treated with early or late stenting, but there is insufficient evidence to 
suggest this as a routine treatment (Donas et al. 2008; DuBose et al. 2008).
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2. PotentiaL oF Cea in stroke PreVention
2.1. indicAtions 
Prevention remains the best approach to reduce the burden of stroke. Approximately 
30–50% of ischaemic strokes are caused by atheroembolism; a large proportion of 
these are related to atherosclerotic stenosis in the extracranial vessels, and carotid 
bifurcation in particular (Weimar et al. 2006, Marnane et al. 2010). Approximately 
30–40% of patients who suffer a stroke had a preceding transient ischaemic attack 
(TIA) or minor stroke, which presents an opportunity for prevention (Rothwell et al. 
2006). Around 5% of TIA patients presenting to rapid access clinics end up having 
carotid surgery (Lavallée et al. 2007, Rothwell et al. 2007). 
2.2. rAndoMised controlled triAls
2.2.1. syMptoMAtic cArotid stenosis
Symptomatic patients with carotid stenosis were randomised to surgery or medical 
treatment in three large controlled trials. The Veterans Affairs Study (VA) (Mayberg 
et al. 1991), the NASCET (North American Symptomatic Endarterectomy Trial Col-
laborators 1991) and the European Carotid Surgery Trial (ECST) (European Carotid 
Surgery Trialists’ Collaborative Group 1998) delivered level I evidence on the ef-
ficacy of CEA in the prevention of stroke in symptomatic patients with 70–99% 
stenosis of the ipsilateral ICA (Naylor 2006). VA was originally reported in 1991 
with a non-significant trend in favour of surgery, but it was stopped early when the 
initial results of the two larger studies were reported. The final results of NASCET 
and ECST were reported in 1998. 
The data of NASCET and ECST were combined and recalculated by the Carotid 
Endarterectomy Trialists Collaboration (CETC) (Rothwell et al. 2003), and they 
showed that medically treated patients with symptomatic high grade (70–99%) 
ipsilateral ICA stenosis have a 33% risk of suffering any kind of stroke within 5 
years, compared with 17% when treated surgically. This estimation gives an ab-
solute risk reduction of 16% in favour of surgery. This means that one stroke could 
be prevented in five years’ time if six operations were performed in this patient 
group (number needed to treat, NNT = 6), provided that the operative morbidity 
and mortality is 6% or less. For moderate (50–69%) stenosis, the net benefit was 
marginal, but significant, with a 4.6% 5-year absolute risk reduction (NNT = 22). 
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As the combined data included 6,092 patients, with 35,000 patient years of 
follow-up, several subgroup analyses could be performed. The results have been 
widely revisited and several international guidelines have been published (Leys 
et al. 2004; Hobson et al. 2008; Liapis et al. 2009). Subgroups who benefit most 
from surgery have been identified, and patient characteristics should be taken into 
account in the decision-making process of clinical practice. On the other hand, it 
has to be kept in mind that the randomising process was not stratified based on 
these post hoc subgroup analyses, the validity of which can be questioned. 
Over time, the progress in medical management, mainly statins, has presented 
a major setback for the application of the findings of these trials. Statins were not 
in use at the time of the trials, and some recent data suggest a significant protective 
effect of state of the art medical management, especially for patients with carotid 
stenosis. Some authors have therefore questioned the value of these randomised 
trials and suggested a more conservative approach towards symptomatic carotid 
artery disease, at least in moderate risk groups (Amarenco et al. 2006; Sillesen et 
al. 2008). On the other hand, none of the more recent randomised trials on CEA 
versus angioplasty and stenting for symptomatic carotid stenosis have yet included 
a conservative arm. 
2.2.2. AsyMptoMAtic cArotid stenosis
Asymptomatic Carotid Atherosclerosis Study (Executive Committee for the Asymp-
tomatic Carotid Atherosclerosis Study 1995) was published in the United States in 
1995 and was followed by a large increase in the number of CEA procedures in the 
US (Rechtenwald et al. 2007). Fairly similar results could be seen in a larger Eu-
ropean Asymptomatic Carotid Surgery Trial (ACST) published much later in 2004 
(MRC Asymptomatic Carotid Surgery Trial (ACST) Collaborative Group 2004). 
Both studies showed a small but significant absolute risk reduction in the risk of 
stroke at 5 years (5.4–5.9%). The risk of stroke in patients with asymptomatic ca-
rotid stenosis is low, only 2% per annum in the ACST, and therefore the rationale 
for performing CEA on asymptomatic patients is still controversial and requires a 
very low surgical complication rate. The subgroup most likely to benefit from CEA 
for asymptomatic stenosis is men under the age of 75.
2.2.3. surgery versus AngioplAsty And stenting 
Surgery is not the only option for treating carotid artery stenosis. As in several other 
locations, less invasive angioradiological methods have been applied in the carotid 
territory as well. Carotid angioplasty and stenting (CAS) is widely used for both 
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symptomatic and asymtomatic carotid stenosis treatment, even though scientific 
evidence supports the use of CAS only in carefully selected cases. A number of ran-
domised studies of various quality have been performed, and several meta-analyses 
have searched for a definite answer to this question. As with all emerging technol-
ogy, one major drawback of the randomised studies has been the variability and 
development in the angioplasty and stenting skills and equipment, and therefore 
many otherwise well-performed RCTs have been heavily criticised (Eckstein et al. 
2008; Mas et al. 2006; Ricotta and Malgor 2008; Ederle et al. 2009a). The most 
recent meta-analyses, performed after the publication of the so far largest and most 
comprehensive study, which enrolled symptomatic patients only, the International 
Carotid Stenting Study (ICSS) (International Carotid Stenting Study investigators 
2010), have concluded that surgery is better than CAS (Ederle et al. 2009b; Meier 
et al. 2010). A corresponding North American study (Carotid Revascularization 
Endarterectomy versus Stenting Trial, CREST) (Lal and Brott 2009; Brott et al. 
2010; Mantese et al. 2010) had great difficulties in recruiting symptomatic patients. 
The trial was therefore delayed, and ultimately also included asymptomatic patients. 
The CREST and ICSS showed similar results for symptomatic patients, favouring 
CEA over CAS. In a pooled analysis of three RCTs on CAS, the patients’ age had 
a significant impact on the treatment effect: in patients <70 years old (median), 
the 120-day stroke or death risk was 5.8% in CAS and 5.7% in CEA (RR 1.00, 
0.68–1.47); in patients 70 years or older, there was an estimated two-fold increase 
in risk with CAS over CEA (12.0% vs. 5.9%, RR 2.04, 1.48–2.82, interaction p = 
0.0053) (Bonati et al. 2011). Trials for asymptomatic patients only are underway, 
but seem to have problems in recruiting patients (Rudarakanchana et al. 2009).
2.3. issues to consider in pAtient selection  
2.3.1. syMptoM
The nature of the preceding symptom seems to affect the risk of recurrent stroke. 
Patients with high grade stenosis who have suffered a stroke or clear hemispheric 
TIA have a significantly higher risk of a new stroke than patients with transient 
ocular symptoms, e.g. OR 3.23 (95% CI, 1.47 to 7.12) in NASCET (Streifler et al. 
1995). On the other hand, patients with repetitive symptoms have a high risk of 
stroke (Leira et al. 2004; Gorlitzer et al. 2009). It is controversial whether patient 
with major strokes and good recovery after acute treatment should be operated 
emergently, or whether a deferred policy should be applied (McPherson et al. 2001; 
Bartoli M et al. 2009; Crozier et al. 2011). Major strokes, i.e. infarcts that eliminated 
useful function in the affected territory, were excluded from NASCET and ECST, 
and thus there are no large scale randomised data of surgery after major stroke. 
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However, patients with stroke are considered to have a 2 to 21% risk of recurrent 
stroke and therefore could be candidates for surgery (Pritz 1997; Crozier et al. 2011).
2.3.2. grAde of stenosis
The studies of symptomatic stenosis have recognised the grade of the stenosis as 
the most important predictive factor in the decision-making process. The stenoses 
have been graded as less than 50% (low grade), 50–69% (moderate) and ≥ 70% 
(high grade) stenosis. From the CETC data, some quite definite recommendations 
have been processed (Rothwell et al.  2003). Obviously, several other factors affect 
the risk of embolisation, but the stenosis grade can be fairly reliably measured, and 
therefore it is easy to use. However, it has to be remembered that the major RCT 
data is derived from digital substraction angiographic image data, and today most 
patients are examined with other modalities prior to surgery.
Soft and irregular plaques with ulceration have been shown to have a greater po-
tential of sending emboli, but despite a vast number of studies, controversy remains 
about which criteria should be used in the diagnostics (Walker et al. 2002; Rubin 
et al. 2006; Nicolaides et al. 2010).
2.3.3. other extrAcrAniAl Arteries
Contralateral stenosis or occlusion and stenoses in the vertebral arteries also af-
fect the total cerebral blood supply. If several arteries are severely stenosed, the 
patients are more likely to have unspecific orthostatic symptoms of dizziness or 
syncope (Persoon et al. 2009). It has been suggested that a contralateral stenosis 
or occlusion increases the risk of complications of CEA. In a large trial comparing 
locoregional anaesthesia (LA) with general anaesthesia (GA) during CEA, the GA 
group had a higher but not significantly elevated risk of complications in the pres-
ence of contralateral occlusion (GALA Trial Collaborative Group 2008).
2.3.4. gender
In the pooled CETC data, women carried a higher perioperative risk of stroke. 
The symptomatic male patients seem to have a higher risk of recurrent stroke and 
gain more from CEA. The gender difference was also seen in both large trials on 
asymptomatic patients (Rothwell et al. 2004b, Rothwell and Goldstein 2004). The 
incidence of stroke is higher in men until the age of 85 (Rosamond et al. 2007). 
There is a trend towards higher mortality, increased stroke severity, and poorer 
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functional outcome in women. Women are also less likely to have carotid duplex 
imaging (32.8% vs. 44.0%). Women tend to have more cardioembolic strokes than 
men and are less likely to have carotid surgery (0.3 vs. 1.5% of all stroke patients) 
(Di Carlo et al. 2003; Poisson et al. 2010). In a systematic review of 25 studies, 
women seemed to suffer from a higher perioperative risk of stroke or death (OR 1.31) 
(Bond et al. 2005). The reasons for these differences are multifactorial and partly 
unknown, but there are differences in the pathology of symptomatic atherosclerotic 
plaque, women having a greater frequency of transient endothelial erosion than 
plaque rupture (Joakimsen et al. 1999, Turtzo and McCullough 2008).
2.3.5. Age
In the trials randomising symptomatic patients, the older patients benefited more 
from surgery. In NASCET, patients over 79 were originally excluded, but they were 
included after the initial reports showed a high benefit in the older group. This is 
possible due to the fact that as most recurrent strokes are seen within 3 months 
of the original symptom, the benefits are also seen quite quickly.  In the trials 
for asymptomatic patients, the benefit from surgery may be seen mainly in those 
patients who live long enough, and thus in both ACST and ACAS (Executive Com-
mittee for the Asymptomatic Carotid Atherosclerosis Study 1995) the main group 
to benefit was those younger than 75 with few comorbidities (Naylor 2006).  
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3. ProBLems in tHe aPPLiCaBiLity oF  
tHe randomised studies
3.1 do We find the correct pAtients?
From the point of view of population benefit, the CEA capacity should be addressed 
to those patients who are most likely to suffer a stroke and who do not have a high 
perioperative risk. The subgroup analyses of the randomised studies help to identify 
such patient groups. However, it may still be difficult to find the correct patients 
from the community for several reasons: the patients may not seek medical atten-
tion to their transient symptoms. The medical personnel that is the first to meet 
the symptomatic patient may not be aware of the treatment possibilities and the 
need for further neurological evaluation. The imaging studies may not be ordered 
immediately, but are scheduled as outpatient investigations, and thus delays are 
inevitable. If the symptomatic patients with a high grade stenosis would be the 
only ones considered as candidates for CEA, the estimated need for CEA would 
be around 100-200 / a million inhabitants in the Western countries (Ferris 1998). 
However, most centres performing CEA also operate on patients with moderate 
grade (50–69%) stenosis, asymptomatic patients, as well as patients with non-
specific symptoms. Thus, in order to treat all the patients who benefit from CEA 
surgically, the vascular surgical capacity for CEA should be significantly higher. 
3.2. inclusion And exclusion criteriA 
It is very important to understand that if the operation is considered justified by 
information gained in the randomised studies, the patient should fulfil the inclusion 
criteria of the trials. The general applicability of the results of a trial decreases if 
the patient group is very strictly defined. To assess the generalisability of any RCT 
results, it is necessary to know how many of the potential candidates for CEA were 
actually included. On the other hand, when the sample size of a trial increases, the 
possibility to answer a specific question will also increase. However, it will dimin-
ish if the inclusion criteria are too loose. Physicians will inevitably meet patients 
who do not fulfil the inclusion criteria in every day practice, and they will have to 
extrapolate the trial evidence to be able to treat those patients. 
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NASCET included 2,885 patients with over 29% stenosis, who had been sympto-
matic within the preceding 120 days and who did not have significant comorbidities. 
The enrolment period was from 1987 to 1996, and the follow-up lasted until 1998. 
Patients over the age of 79 were included only after 1991. Patients were excluded 
if they had significant organ failure or cancer that was likely to cause death within 
5 years or if they had a cardiac valvular or rhythm abnormality. Patients who had 
uncontrolled hypertension or diabetes or who had experienced unstable angina or 
myocardial infarction were considered temporarily ineligible. The majority (60%) 
had had ocular or hemispheric transient ischaemic attacks, and 40% had suffered 
a stroke, but a major disabling stroke was an exclusion criteria (North American 
Symptomatic Endarterectomy Trial Collaborators 1991, Barnett et al. 1998). Only 
one third of the patients operated on in the participating units during the same time 
period were included in the study. Furthermore, registered national complication 
rates for all operated patients were higher than those of the patients included in 
the trials (Wennberg et al. 1998, Bunch  and Kresowik 2004).
ECST enrolled 3,024 patients from 1981 to 1994, and the final results were 
published in 1998. The patients had been symptomatic within the last 6 months. 
Major disabling strokes were excluded, and 50% of the patients had had a stroke. 
The others had either ocular or hemispheric TIA. If another, for example a cardiac 
cause for embolus was present, the patient was not included (European Carotid 
Surgery Trialists’ Collaborative Group 1998).
The ACAS study, published in 1995, included asymptomatic patients with over 
60% carotid stenosis who were diagnosed with ultrasound and verified with digital 
substraction angiography (DSA) imaging if they were randomised to the surgical 
arm of the trial. The patients were not supposed to have had any related symptoms 
for the preceding 5 years, and all patients over 79 years of age as well as those with 
less than a 5-year life expectancy were excluded. They were also not supposed to 
have had a contralateral ischaemic event within 45 days and not to suffer from a 
specific disease that could seriously complicate CEA (Executive Committee for the 
Asymptomatic Carotid Atherosclerosis Study 1995).
ACST included 3,120 patients with unilateral or bilateral carotid artery stenosis 
of at least 60% on ultrasound and no prior stroke, TIA or other relevant neurologi-
cal symptoms within the last 6 months. The exclusion criteria were similar to the 
ACAS, and the patient was not supposed to have any probable source of cardiac 
emboli or any major life-threatening condition likely to preclude long-term follow-
up (MRC Asymptomatic Carotid Surgery Trial (ACST) Collaborative Group 2004).
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3.3. defining the grAde of stenosis
The NASCET method of measuring the stenosis has been generally accepted and 
should be used in angiographic diagnostics. In both NASCET and ECST, digital 
substraction angiography (DSA) was used, and thus the differences in the grading 
of the stenosis can affect patient selection as the more non-invasive modalities 
have virtually replaced DSA as the first-line imaging option. Computer tomog-
raphy angiography (CTA) and magnetic resonance imaging angiography (MRA) 
are non-invasive modalities, and they are widely used at larger stroke units. In a 
recent study by Andizei and co-workers, the sensitivity / specificity against DSA 
for CTA was 95/98% and 93/97% for steady state MRA, far better than for duplex 
Doppler ultrasound (DD) (sensitivity/specificity was 67/87%) (Andizei et al. 2011). 
DD is also far more operator-dependent, and no image is stored for later objective 
comparisons. Another disadvantage of the DD is that it does not show the ICA or 
intracranial vessels distal to the bifurcation area. The CETC data have been recal-
culated so that the figures represent the NASCET criteria (Rothwell et al. 2006).
3.4. iMportAnce of regionAl co-operAtion And  
regionAl differences 
In order to utilise the full stroke prevention power of CEA, a population-based 
approach should be implemented. All health care professionals should be made 
aware of the local organisational structure, and guidelines should be written and 
followed in daily practice. The units where stroke patients are treated should be 
large enough to have the possibility for immediate vascular imaging. It has been 
shown that TIA clinics (Lavallée et al. 2007, Rothwell et al. 2007) are effective in 
stroke prevention and that hospitals with standardised stroke units perform better 
than general hospitals in stroke outcomes (Meretoja et al. 2010a). Although only 
about 5% of the patients referred to the TIA clinics will be operated on, the consulta-
tion patterns should be emphasised, developed and standardised. The co-operation 
between primary health care, paramedic personnel, neurologists, radiologists and 
vascular surgeons should be streamlined to ensure that the patients and their treat-
ment are in focus on a 24/7 basis. 
There are major regional differences in stroke prevention and the provision of 
vascular surgical services. Bunch and co-workers studied CEA processes of care 
and outcomes in the Medicare population of 10 US states and found considerable 
state-to-state variation. The 30d combined event rates varied from 4.4% to 10.9% 
in symptomatic and from 1.4% to 6.0% in asymptomatic patients. They also found 
significant proportions of patients who were not treated according to the generally 
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accepted guidelines. For example, only 67% of the patients received preoperative 
(within 24h) antiplatelet therapy although there is strong evidence to support its 
use. Moreover, 40% of the patients were operated due to a non-specific indication, 
that is, an indication that was not an asymptomatic stenosis, nor did it fulfil the 
inclusion criteria for the major RCTs for symptomatic patients. 40% of the operated 
patients were asymptomatic, and only 20% would have been eligible for NASCET 
or ECST. (Bunch et al. 2004)
The Finnish National Research and Development Centre for Welfare and Health 
(STAKES), University hospital districts and the Social Insurance Institution co-
operated in a national project to evaluate regional differences in stroke care, the 
PERFECT stroke project (PERFormance, Effectiveness and Cost of Treatment epi-
sodes). Major regional differences were found in the process of care and total costs. 
In 2003, the percentage of stroke patients who ended up having CEA varied between 
0.4% and 3.4% in different regions. It was not possible to explore the reasons for 
these differences in more detail in the project, but it can be assumed that they are 
at least partly attributable to the process of care and the implementation of scien-
tific evidence to clinical practice (Meretoja et al. 2010b).
The national vascular register in Sweden, Swedvasc, reports annually the out-
come differences of CEA in hospitals throughout Sweden. For CEA in 2009, the 
rate of “any ipsilateral stroke or mortality” varied between 0.0% (0/98 CEAs) and 
20.0% (5/25). If the hospitals with over 50 CEAs/year were the only ones inclu-
ded, the variation would still be between 0.0% (0/98) and 6.8% (4/59), while the 
total national ipsilateral complication rate was 3.5% (41/1180). Even though the 
reporting standards may differ between hospitals, it has to be remembered that 
Swedvasc is a well-validated 20-year old database that is meticulously administe-
red. The differences are similar in Finland, and they may reflect true problems in 
the processes of care and should therefore be objectively explored (Kantonen et al. 
1997; Swedvasc report 2010).
3.5. hospitAl results And dAtA reliAbility
Finnish law regulates that treatment episodes must be registered in hospital dis-
charge registries, which are maintained by the government. However, it is not man-
datory to report outcome data. Quality control and hospital results are retrieved 
from separate registries or research projects, which require additional personnel 
and project funding. The level of reporting is variable due to the lack of standardised 
national reporting protocols. 
Wennberg and co-workers compared the NASCET data to Medicare 30-day 
mortality data from the same hospitals and also to non-trial hospital data (Wenn-
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berg et al. 1998). They found that the trial hospitals had much higher annual pro-
cedure volumes, something that has previously been linked to lower complication 
rates. However, they also found that the crude and adjusted (controlled for age, 
sex, race, comorbidity and urgency of admission) 30-day mortality rates following 
carotid endarterectomy differed significantly between the trial data and the Medicare 
data within the trial hospitals. For example, overall mortality in the trial hospitals 
(86 hospitals, 6,510 patients) was 1.4% and therefore higher than the NASCET 
mortality of 0.6% in these hospitals. While the patient characteristics were similar 
between the trial and non-trial institutions, the trial hospitals had 20% lower death 
rates. The trial hospitals performed only 6% of the CEAs performed in the US at 
the same time period. The authors conclude that it should be questioned whether 
the NASCET results reflect the daily practice, and whether they are applicable to 
other patients and non-trial hospitals or not.
The available registers are most reliable when only treatment episodes or mor-
tality are concerned. On the other hand, the results of treatment including the 
outcome of patients should be readily available in order to maintain and improve 
the quality of care. Input to registers about follow-up data is difficult to obtain, and 
therefore these quality issues should be addressed within focused administrative 
and research projects.
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4. FaCtors aFFeCting tHe resuLt oF surgery
4.1. the role of delAy, Why it is iMportAnt to  
Act urgently
The combined data of ECST and NASCET have been revisited. This data pool shows 
that the delay between symptom and surgery is a major factor in the effectiveness 
of CEA. Women with a moderate stenosis benefit in particular if the operation is 
performed within 2 weeks or one month from the symptom. If the delay is longer 
than this, then the surgery will be statistically questionable (Rothwell et al. 2004a; 
Naylor 2006). However, it has to be remembered that the patients were not ran-
domised against the timing of the surgery, but this analysis is a post hoc analysis 
which is retrospectively extrapolated from the data. Urgent or semi-urgent surgery 
may increase the risk of perioperative complications, but it still seems that in ECST 
and NASCET the delay was more dangerous than the increase in perioperative 
complications, and thus a higher complication rate may be accepted if the delay is 
short (Naylor 2008). On the other hand, this seems mainly to be true for females 
and for moderate stenosis, whereas males with high-grade stenosis, which form the 
most likely group to undergo CEA, can expect good benefits irrespective of whether 
they are operated early or later after their symptom (Rothwell et al. 2004b).
A meta-analysis and systematic review by Rerkasem and Rothwell in 2009 re-
vealed that the pooled absolute risks of stroke and death after urgent CEA were high 
in patients with stroke-in-evolution (20.2%) and in patients with crescendo TIA 
(11.4%). However, there was no significant difference between early and later CEA 
in neurologically stable patients with recent TIA or non-disabling stroke (neither 
comparing < 1 week versus ≥ 1 week nor < 2 weeks versus ≥ 2 weeks) (Rerkasem 
and Rothwell 2009a). Because the risk of recurrent stroke is the highest soon after 
a minor stroke or TIA, early surgery of stable patients is most likely appropriate.
Urgent treatment and investigation of TIA has been accepted as the best clinical 
practice in many neurological departments, as it has been established that as many 
as 17% of the patients with TIA may have a stroke within the first 72h. However, 
after the first few days quite a few strokes are also seen (Rothwell 2006; Wu et 
al. 2007; Lasserson 2009). The question remains whether all patients should be 
operated on within 1–2 days after the first warning sign, and if so, from where the 
resources to perform these operations would come. 
The Early use of eXisting PREventive Strategies for Stroke (EXPRESS) study 
(Rothwell et al. 2007) was a population-based phase1 versus phase2 study con-
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ducted in Oxford, which focused on the effect of early assessment and treatment 
of TIA or minor stroke on the risk of early recurrent stroke. The main difference 
between the treatment periods was that the median (IQR) delay to first prescrip-
tion of treatment fell from 20 (8–53) days to 1 (1–3) day, and at the same time 
the 90-day risk of recurrent stroke decreased from 10.3% (32/310 patients) to 
2.1% (6/281 patients) (adjusted hazard ratio 0.20, 95% CI 0.08–0.49; p=0.0001). 
However, this effect was probably mainly due to urgent medical treatment as only 
5.5% (17/302 in phase 1 and 15/278 in phase 2) of the patients had CEA, and thus 
the total effect of surgery remains low.
In Paris, a SOS-TIA clinic with 24h access entered 845 TIA patients into a stroke 
prevention programme between 2003 and 2005 (Lavallée et al. 2007). Forty-three 
(5.1%) patients had urgent CEA, and 44 (5.2%) patients were treated for atrial 
fibrillation with anticoagulants. The 90-day stroke rate was low (1.2%) against the 
ABCD2 score-based estimation of 6.0% (Johnston et al. 2007, Table 8).
The ICSS study randomised 1,713 symptomatic patients to be treated either by 
CEA or CAS. The investigators reported that only 3 strokes (1.8 ‰) occurred while 
waiting for the allocated treatment. The median delay from symptom to treatment 
was 35 days for CAS and 40 days for CEA. On the other hand, the median delay 
from randomisation to operation was 9 vs. 11 days for CAS and CEA, respectively. 
Thus, the early strokes which occurred prior to randomisation were probably mis-
sed (International Carotid Stenting Study investigators 2010).
In the United Kingdom, only 20% of symptomatic patients had surgery wit-
hin the two-week target time set by the National Institute of Health and Clini-
cal Excellence (NICE) in 2008 (Halliday et al. 2009). In 2004–2006, only 7% of 
the Swedvasc operations were performed within 2 weeks (Johansson and Wester 
2008). However, the Swedvasc reports from 2009 and 2010 showed that efforts 
in shortening the delay have been successful and the median time in Sweden had 
gone down to 12 in 2009 and to 9 days in 2010, but there is still much variation 
(Swedvasc reports 2010 and 2011).
4.2. hospitAl And surgeon voluMe 
High volume centres seem to perform better than centres that present low annual 
number of CEAs (Nazarian et al. 2008; Holt et al. 2007). A meta-analysis performed 
by Holt and co-workers included 21 studies in a pooled analysis with 885,034 op-
erations from all over the world. Overall, the pooled effect estimate was an odds 
ratio of 0.78 in favour of surgery at higher volume units, with a critical volume 
threshold of 79 CEAs per annum. Nazarian et al. presented a rigorous statistical 
analysis based on 10 years of data from the Maryland hospital discharge register 
with 22,772 operations. Their study only included in-hospital deaths. They found 
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that high volume centres (>130 CEAs per year) had an odds ratio of 0.945 of death 
per additional procedure. It seems obvious that an active centralised system allows 
the systematic improvement of treatment strategies. 
Surgeon-specific volume is also an important factor when minimising complica-
tions (Kantonen et al. 1998). Different optimal annual numbers have been suggested, 
but it seems logical that routine and experience improve the results. Cowan and 
co-workers analysed 35,821 carotid operations from a registry-based National In-
patient Sample in the United States, representing a random representative sample 
of the whole country (Cowan et al. 2002). They showed that in-hospital mortality, 
postoperative stroke and prolonged length of stay decreased with increasing number 
of annual operations per surgeon. They categorised the surgeons into three groups: 
low volume (<10 procedures/year), medium volume (11-29 CEA/y) and high volume 
(≥30 CEA/y). Observed mortality graded by surgeon volume was 0.4% for high-
volume surgeons, 0.6% for medium-volume surgeons, and 1.1% for low-volume 
surgeons (p< 0.001). The postoperative stroke rate was 1.1% for high-volume sur-
geons, 1.6% for medium-volume surgeons, and 2.0% for low-volume surgeons (p 
< 0.001). Surgeon speciality had no statistically significant effect on mortality or 
postoperative stroke. High-volume surgeons performed 51.9% of the operations. 
4.3. technicAl Aspects And AnAesthesiA 
4.3.1. priMAry closure versus pAtch AngioplAsty 
High-quality evidence supports the use of patch but does not give a definite answer 
to the choice of graft material (vein vs. synthetic). A Cochrane review from 2004 and 
an update from 2009 (Bond et al. 2004; Rerkasem and Rothwell 2009b) concerning 
patch angioplasty versus primary closure included ten trials with 2,157 operations. 
Patch angioplasty was associated with a reduced risk of ipsilateral stroke during 
the perioperative period (OR 0.31, 95%, CI 0.15 to 0.63, p=0.001) and long-term 
follow-up (OR 0.32, 95%, CI 0.16 to 0.63, p=0.001). Perioperative arterial occlu-
sion was also less frequent in the patch groups (OR 0.18, 95%, CI 0.08 to 0.41, 
p<0.0001), and long-term follow-up restenosis rate was decreased in eight trials 
(OR 0.24, 95%, CI 0.17 to 0.34, p<0.0001). The authors commented that the overall 
quality of the trials was generally poor and the sample sizes relatively small. The 
data were not available from all trials, and there was a significant loss to follow-up. 
Neither long-term nor perioperative deaths were associated with closure groups. 
The authors concluded that limited evidence suggests that carotid angioplasty may 
reduce the risk of perioperative arterial occlusion and restenosis. It would also 
appear to reduce the risk of ipsilateral stroke. Moreover, there is a nonsignificant 
trend towards a reduction in perioperative any stroke rate and all-cause case fatality 
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(Rerkasem and Rothwell 2009b). Thus, in the absence of other evidence, it would 
seem logical to advocate patch angioplasty over primary closure. The choice of graft 
material seems controversial, and there is not enough evidence to support one ma-
terial over another. If vein patch closure is used, there are data from observational 
studies (Riles et al. 1990; Scott et al. 1992; O´Hara et al. 2002) that show a higher 
rupture rate if the vein is harvested from the ankle. Therefore, if vein material was 
used, it would seem more appropriate to use the great saphenous vein in the groin. 
4.3.2. conventionAl versus eversion endArterectoMy 
Conventional CEA includes a longitudinal incision over the stenosis, endarterec-
tomy and closure either primarily or with patch angioplasty. The distal intimal 
flaps may or may not be fixated with fine sutures in order to prevent ICA or CCA 
dissection. Eversion endarterectomy includes a transsection and reimplantation of 
the proximal ICA. When the transsected ICA is everted and the plaque removed, 
shunting becomes more difficult or impossible, and the distal intimal flap may not 
be fixated. Thus, it may sometimes be necessary to convert the eversion technique to 
longitudinal arteriotomy and patch closure (Brothers 2005; Crawford et al. 2007). 
A Cochrane analysis from 2001 concluded that eversion CEA can be associated with 
a low risk of arterial occlusion and restenosis. The reduced restenosis rates did not 
seem to be associated with either perioperative or late stroke risk (Cao et al. 2004). 
Thus, according to European Society for Vascular Surgery (ESVS) guidelines, the 
choice of endarterectomy should depend on the experience and familiarity of the 
individual surgeon (Liapis et al. 2009).
4.3.3. routine versus selective shunting 
Recent European guidelines reviewed the studies from which data on whether to 
use routine shunting or not could be extrapolated. They found no evidence to sup-
port routine shunting during CEA. They also concluded that there is little evidence 
to support the use of one form of monitoring over another in selecting patients 
requiring a shunt (Liapis et al. 2009).
4.3.4. AntejugulAr versus retrojugulAr ApproAch
The carotid bifurcation is normally approached from an oblique incision following 
the anterior border of the sternocleidomastoid muscle. Some surgeons prefer to 
use a more horizontal incision in order to make the scar less visible. Preoperative 
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marking of the bifurcation level with ultrasound may be used in the planning of the 
incision. The internal jugular vein is the anatomic landmark under the sternoclei-
domastoid muscle. Either ante- or retrojugular approach may be used. Surgeons 
preferring the retrojugular approach state that the ICA is easier to mobilise a little 
higher up, which consequently improves the safety of the operation. The antejugular 
approach with facial vein ligation is the more traditional one. When choosing the 
approach, the main concern is cranial nerve injury. One randomised effort to study 
this has been made in Germany. The study identified more transient cranial nerve 
injuries (31% vs. 6%, p=0.0014) in the retrojugular approach, which is why the 
study was aborted early and consequently lost its power. This early postoperative 
impairment was, however, not statistically significant at the follow-up examination 
at 6 months (2.4% vs. 0.0%) (Stehr et al. 2008). It still seems that both approaches 
may be used provided that cranial nerve injury rates remain acceptable (Lutz et al. 
2009; Kluk et al. 2009).
4.3.5. generAl versus locAl AnAesthesiA 
The surgeons who advocate local over general anaesthesia may have a very strong 
personal opinion as the patients recover faster with less cognitive problems im-
mediately after the operation. It may also be less stressful for the surgeon as he 
can be sure that the patient will not get new neurological symptoms during carotid 
clamping. On the other hand, it is logical that local anaesthesia does not protect from 
embolic complications, and if patient discomfort leads to a need for expediting the 
operation, it may even be harmful in terms of endarterectomy and patching qual-
ity. Recently, a large randomised study was performed in order to find out if one 
of the anaesthesia methods provided a clinical benefit for the patients (GALA Trial 
Collaborative Group 2008). The major complication rates in well-performed CEAs 
are low, and a large sample size of 3,526 operations was consequently included. 
The GALA trial showed no difference in the primary outcome events (MI, stroke or 
death 30d post surgery) for the whole patient group, different age groups or high 
versus low-risk patients. A subgroup of 310 patients with contralateral carotid artery 
occlusion showed a nonsignificant trend for a smaller complication rate in the local 
anaesthesia group (8/160 (5.0%) versus 15/150 (10.0%), p for interaction 0.098). 
The complication rates in the GALA trial were lower than in NASCET and ECST. 
Other trials were too small to allow reliable conclusions to be drawn (Rerkasem 
and Rothwell 2009 c). Therefore, it may be concluded that both methods are safe, 
and patients with contralateral carotid occlusion may benefit from CEA in local 
anaesthesia.
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5. registries and outCome monitoring
High-quality CEA provision cannot be reached without quality control. Guidelines 
are based on RCTs whenever possible. However, actual practice is rarely a clean 
reflection of the RCT setups, and the guidelines may be poorly followed in clinical 
practice (Holloway et al. 2000; Grol and Grimshaw 2003). Therefore, it is important 
to know how well actual practice compares with an “ideal situation” of randomised 
trials. Registries provide a possibility to perform this comparison, and they can be 
used as valuable quality improvement tools (Schwamm et al. 2006). Implementing 
a new registry is resource-intensive, and several economical, work force, patient 
privacy and legislation issues have to be addressed. The annual cost of the Canadian 
stroke registry was $1 million, and it was still not able to provide a comprehensive 
nationwide database. This was, however, at least partly due to legislative obstacles: 
the informed consent required was obtainable only for 51% of the patients (Tu et 
al. 2004). Meretoja and co-workers calculated that if data entry took 30 minutes 
per patient, this would increase the work-load by one fully employed person for 
every 3,000 patients (Meretoja et al. 2010 b).
5.1. different registry types
Registries may have various interests. Scientific research requires maximal reliability 
of the data, while health care planning needs maximal coverage. Quality improve-
ment projects should gain information on clinically relevant processes and outcome. 
Most often, hospital administration or national legislation requires registries on 
operation and treatment volumes, costs and crude outcome measures like death. 
These registries are often insufficient to give more detailed data that would be clini-
cally important, including the outcome of patients. Clinical and scientific disease 
registries address more specific questions for treatment monitoring, quality control 
and research purposes. National disease or treatment-specific databases have been 
instituted in several countries for many different purposes. Disease registries often 
rely upon voluntary inclusion, and the nationwide coverage and allocated resources 
are variable (Mehta et al. 2002, Meretoja et al. 2010b). 
The Scandinavian countries have a long tradition of prospective data collection 
of all reconstructive vascular procedures. Swedvasc in Sweden, Finnvasc in Finland, 
Karbase in Denmark and Norkar in Norway have all registered a vast number of 
patients. The most comprehensive of these is Swedvasc with over 20 years of re-
gistered data, continuous data validation and reporting (Swedvasc report 2010). 
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In addition to a comprehensive annual report, a large number of focused publi-
cations have been published from the data. This scientific activity and systematic 
funding are probably the main reasons for the success of Swedvasc. The Swedish 
Association of Local Authorities and Regions provides funding for the Registry. 
Finnvasc, which operated in Finland from 1991 to 1999, was another early register 
with nationwide coverage. It was the first register in the world to cover the whole 
country, and it operated on a voluntary basis and with minimal costs (Salenius 1992). 
Finnvasc could present validated nationwide data during 1991–1995 and variable 
participation thereafter (Lepäntalo et al. 1994, Kantonen et al. 1997). However, the 
implementation of a new personal registry law at the turn of the millennium made 
it impossible for the register to continue. Thereafter, regional registries have conti-
nued to gather data. The hospital district of Helsinki and Uusimaa can now present 
20 years of registered data for a catchment area of 1.45 million people (Lepäntalo 
et al. 2008). Karbase (www.karbase.dk) is the Danish vascular registry, which has 
been collecting data since 1996. Karbase experienced major legislative problems 
in 2002–2003, when a national indicator project declared many national registers 
that collected data without a written consent illegal. After strong support from the 
physicians and local newspapers, the legislation was changed in 2003, and data 
collection could continue with only some limitations.
5.2. reliAbility of the registries 
Perhaps the main concern with all registered data is the reliability of the data. 
Therefore, regular audits and reports are important in improving the quality of the 
registries. It is generally accepted that it would be ideal to cross-match different 
registries kept by different register holders and take advantage of the fact that many 
patients are included in several different registries (e.g. many vascular patients 
are included in diabetes and stroke registries). This is seldom possible due to data 
privacy issues, database differences and different interests of the register holders 
(Mähönen et al. 2000; Troeng et al. 2008; Meretoja et al. 2010b). Within the PER-
FECT stroke project, a cross-linked database was established by combining three 
registers maintained by different register holders (the government, Social Insurance 
Institution and Statistics Finland). The hospital discharge register, national causes 
of death register and the national register of prescribed drugs were cross-linked 
on an individual level with a personal identification number, which is unique for 
every Finnish citizen. (Meretoja et al. 2010 b)
Modern hospital data systems collect an enormous amount of data. However, 
the data are often in many different locations, which are not automatically cross-
linked. The input may in practice be performed retrospectively by persons who 
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are not involved in the treatment and who do not have background knowledge of 
the disease or procedures. This can lead to a loss of important data and a loss of 
reliability. Different private data program providers are often involved, and it is 
in their interest to keep their own program code a secret. Moreover, hospital data 
barriers and firewalls are effective and difficult to work around without the data 
losing its reliability. It is therefore of great importance that these data are validated 
systematically or at least within research projects (Troeng et al. 2008).  
5.3. ApplicAtion of registered dAtA 
A registry has its own value only if the data is used to achieve improved patient 
care. An ideal database would be integrated into hospital patient records, where it 
could automatically gather the relevant information. The reporting systems should 
be pre-planned and readily available to make reports that could be used in patient 
care, health care administration and research. An instant feedback system would 
also increase the quality of input. In vascular surgery, the Swedvasc database seems 
to have been able to achieve such a high level with annual reporting and online 
monitoring (Swedvasc report 2010). Separate focused publications also give more 
depth to a specific analysis of registered data. 
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6. surgery in rare ProBLems oF  
tHe Carotid artery
6.1. surgicAl AnAtoMy And stAndArd lAterAl exposure 
Carotid and vertebral arteries, which are commonly called extracranial arteries 
in the neck, secure cerebral blood flow. The carotid and vertebral circulations are 
united inside the skull as the Circle of Willis, which minimises the risk of cerebral 
damage even if several of the extracranial arteries should be compromised (Abu-
Rahma and Copeland 1998). Variations in the anatomy of the intracranial arter-
ies and the circle of Willis are common, and only about 25% of individuals have 
a complete circle of Willis, while variations are less common in the extracranial 
arteries (Krishnaswamy et al. 2010).
The right CCA arises from the brachiocephalic trunk, emerging normally as the 
first branch from the aortic arch. On the left side, the CCA typically arises directly 
from the aortic arch as the second branch. On both sides, the common carotid 
artery divides into internal and external carotid arteries. The bifurcation of CCA 
is the area which is exposed in most CEA procedures. In order to expose the most 
proximal parts of the CCAs, the sternum or clavicle must be divided. The carotid 
arteries in the neck are reached by following the anterior border of the sternoclei-
domastoid muscle after the division of the external jugular vein and the platysma. 
The omohyoid muscle crosses the CCA and is normally left intact. The posterior 
belly of the digastric muscle, which may be divided without reconstruction in or-
der to gain some extra visibility to the ICA, limits the upper border of the normal 
exposure. In order to gain access to the higher parts of the ICA close to the skull 
base, special techniques, which will be described later, must be utilised. The internal 
jugular vein lies superficial to the CCA and carotid bifurcation. It may be divided 
but is normally retracted either posteriorly by dividing the facial vein or anteriorly 
by dividing small veins from the posterior aspect of the internal jugular vein. The 
superior thyroid artery originates close to the level of the bifurcation either from 
the CCA or as the first branch from the ECA. The carotid body lies at the cranial 
aspect of the carotid bifurcation. When operating around the dorsal aspect of the 
CCA and ICA, care should be taken as the vagal nerve runs parallel to these arteries, 
often within the carotid sheath. The superior laryngeal nerve, a branch from the 
vagal nerve, lies deep in the superior thyroid artery and the ECA. The hypoglossal 
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nerve runs across the ICA cranial to (or seldom at) the level of the bifurcation. The 
glossopharyngeal nerve runs in a similar way cranial to the hypoglossal nerve and 
is normally protected by the styloid process. The most superficial segment of the 
accessory nerve most often lies in a triangle formed by the posterior belly of the 
digastric muscle, internal jugular vein and sternocleidomastoid muscle (Cavalcanti 
et al. 2010). The mandibular branch of the facial nerve must also be avoided as it 
may lie caudal to the parotid gland and be damaged, most often by careless use of 
retractors (Lutz et al. 2009).
6.2. extended exposure techniques 
In order to expose the internal carotid artery closer to the skull base, modifications 
to the standard operation technique are needed (Beretta et al. 2006). Mandibular 
subluxation allows more space for the operation, and it is accompanied by styloid 
process resection, which is intended to expose the ICA at the level of the glossopha-
ryngeal nerve (Dossa et al. 1990). Lateral mandibular osteotomy techniques have 
been used for higher exposure, and vertical osteotomy of the mandibular ramus 
was introduced in this context by Larsen et al. to make better use of physiological 
muscle pull. However, these lateral techniques are limited by the bony structures of 
the skull base (Batzdorf and Gregorius 1983; Mock et al. 1991; Larsen et al. 1992). 
Petrous bone drilling and cervical-to-petrous carotid artery bypass techniques have 
been used in order to gain exposure to the ICA within the bony canal (Alimi et al. 
1996, Eliason et al. 2002; Malikov et al. 2010).
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Aims of the present study
aims oF tHe Present study
1. To define the theoretical potential efficacy and need of carotid surgery in stroke 
prevention in different populations.
2. To validate the reliability of registered data on carotid surgery and its complica-
tions.
3. To compare registry-based data on CEA and its complications from different 
countries. 
4. To explore the referral pathways and reasons for delays from symptom to CEA 
in the Helsinki region and to suggest ways to improve patient flow.
5. To review and discuss the opportunities beyond standard carotid operations in 
tumour and aneurysm surgery and to present a novel multidisciplinary approach 
to operate the internal carotid artery close to the base of the skull.
43
Materials and methods
materiaLs and metHods 
In order to address the question of how to organise carotid surgery effectively, we 
wanted to study different quality issues. First we wanted to evaluate the potential 
of carotid surgery in stroke prevention. We compared the published data from Ox-
ford to the numbers of Helsinki university district and the Sohag governance. The 
main idea was to see how close to the optimal theoretical effect HUCH can perform 
and what potential total effect might be expected if the ideal stroke preventive ca-
rotid surgery would be implemented in Upper Egypt, where almost no CEAs were 
performed at the time of the study. We chose to suggest surgery for symptomatic 
high-grade stenosis only in cases where the estimated NNT to prevent one stroke 
in five years was ca. 6, and assumed that other criteria derived from the RCT data 
can be accomplished. First we compared the population structures and TIA and 
stroke incidences in the three areas. The incidences of TIA and first-ever ischaemic 
stroke in Upper Egypt were derived from a community-based door-to-door survey 
of 25,000 people performed in the Sohag governance (Kandil et al. 2006). The 
corresponding rates in Southern Finland were the average rates from four Finn-
ish stroke epidemiological studies in three different regions in Finland (Aho 1975; 
Sivenius 1982; Kotila 1986; Rissanen 1992), whereas those of Wessex were based 
on the published data of the Oxford Community Stroke Project (Bamford et al. 
1988; Dennis et al. 1989; Ferris et al. 1998). To estimate the proportions of symp-
tomatic patients with operable high-grade carotid stenosis we used published data 
on incidence (Rothwell et al. 2006). The current actual levels of CEA provision were 
derived from local registered data in Finland and Egypt and from published data 
from Oxford. The estimated needs of CEA and the actual/need ratio were reported.
After defining the theoretical impact of surgery for high-grade symptomatic 
stenosis, we wanted to evaluate how well our clinical results compared to the results 
in randomised studies and how reliable the registered data that is used in clini-
cal practice and planning was. We retrieved all CEA operations performed during 
2000–2005 from two different register sources and cross-matched the individual 
patients according to their personal identity number. The Department of Vascular 
Surgery in HUCH has two different registries in use for collecting patient clinical 
data: the local vascular registry, called HUSVASC, which is supported and funded 
by the hospital district of Helsinki and Uusimaa, and the governmental nationwide 
hospital discharge registry (HDR) called HoitoILMOitusrekisteri  HILMO, which at 
the time of the study was maintained by the National Research and Development 
Centre for Welfare and Health (STAKES), Finland. 
HUSVASC was mainly designed to collect data of vascular surgical interest of 
any patient with arterial disease, treated either surgically or endovascularly. HUS-
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VASC also includes the patients in the region previously included in the earlier 
nationwide vascular registry, Finnvasc (Salenius 1992, Lepäntalo et al. 1994). Since 
1967, all operative codes and treatment episodes in Finland have been recorded in 
the Finnish HDR (Mähönen et al. 1997). To identify CEA operations from HUS-
VASC, a quite liberal search policy can be used. For example, operative anatomy, 
indication of operation (stroke, transient ischaemic attacks, amaurosis fugax, and 
asymptomatic stenosis) or the related operative codes may be used. To extract 
data from the HDR a more restricted search policy is mandatory. The nationwide 
operative codes used both in HUSVASC and HDR were retrieved from NOMES-
CO (Nordic-Medico-Statistical Committee) Classification of Surgical Procedures 
(NCSP) (www.helsedirektoratet.no) including codes for thrombendarterectomy 
(PAF), patch angioplasty (PAN), and graft interposition (PAH) of the internal (14), 
external (13), or common carotid arteries (12). We used combined search criteria 
to track any missing CEAs in the period from 2000 to 2005. We assumed that 
this combined search tracked all CEAs. All inconsistent data were crosschecked 
against patient records. Incorrect inclusions, such as carotid area bypasses, were 
discarded manually. To find all the incorrectly coded CEAs, we searched HILMO 
for any surgical or endovascular intervention to the aortic arch and its branches in 
the same period. The results of CEA from both registries were validated and cross-
matched against each other at different levels. After identification, all deficient or 
faulty registrations in HUSVASC were corrected, but we had no access to correct 
any false data in the HDR. To assess the ability of the different registries to give 
comparable rates of morbidity and mortality, we searched both registries for the 
prospectively collected major strokes and fatal events within 30 days after CEA. 
Results were stratified according to the indication of the operation and compared 
to those from the completed HUSVASC dataset. Specific codes for postoperative 
complications (ICD-9 code 997.x and ICD-10 codes Y65, Y69, Y83, and Y88.x) were 
also searched. In order to specify how well a simple search of CEAs (codes PAN14 
for patch angioplasty and PAF 14 for endarterectomy of the internal carotid arte-
ry, normally used for carotid bifurcation endarterectomy as well) would catch the 
operations, we also compared this simplified search with the ones described above. 
Finally, the perioperative morbidity and mortality figures retrieved from the two 
different registries were compared against each other in order to analyse whether 
systematic escape of data was present and whether it would lead to severe problems 
in the reliability of the results in any of the registries or not. 
Further, in order to analyse patient referral pathways and the time from symp-
tom to surgery critically, we identified 100 consecutive symptomatic CEA patients 
operated at HUCH. After approval by the local ethics committee, a retrospective 
data collection of a cohort of 100 consecutive symptomatic patients planned for 
CEA was begun from the day of approval, and the patient records were revisited. 
Data collection included 14 months from August 2007 to October 2008. The me-
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dical history data were collected from the HUSVASC registry, and additional data 
from medical records were added if the registry data were insufficient. During the 
study period, the national recommendations stated that CEA should be performed 
as soon as possible from the index symptom, preferably within 2 weeks (Working 
group appointed by The Finnish Medical Society Duodecim and Finnish Neurolo-
gical Society, Update 2011). 
We categorised different steps of delay to find out where improvements should 
be made. The time from symptom onset, the pathway of reaching vascular surgery 
consultation, rate-limiting steps and the delays before surgery were defined. We 
categorised the delay as: patient-related (the time from the symptom to the first 
health care provider contact); referral delay (the time from the general practitioner 
or private physician referral to the first meeting with a neurologist); neurological 
delay (the time from meeting the first neurologist to the consultation of a vascular 
surgeon); radiological delay (the time from the referral to imaging to the execution 
of the imaging) and surgical delay (the time from the first surgical consultation to 
CEA). These delays overlapped, and their sum was therefore greater than the total 
symptom to knife time (SKT, i.e. the time from the index symptom to CEA). After 
the patient-specific delays had been registered, the data published by the CETC 
(Rothwell et al. 2003, Rothwell and Goldstein 2004, Naylor 2006) were used as 
a reference together with sex and grade of stenosis, and an NNT number for each 
patient could be calculated. The NNT figures could then be used to estimate the 
effectiveness of vascular surgery provision in our practice. The patterns of delay 
could also be used to suggest which actions should be undertaken to reduce delays.
Together with the VASCUNET Steering Committee we also compared registered 
data from several different countries. VASCUNET is a joint venture of European 
vascular registries including data from Australia and New Zealand. The VASCU-
NET is administered and funded by ESVS. In this comparison, it was not possible 
to cross-match patient populations. However, we were able to compare the regis-
tered surgical praxis in different countries and to analyse the theoretical impact of 
CEA in different countries and regions. We had access to data from 53,077 caro-
tid procedures from seven national (Denmark, Hungary, Italy, Norway, Sweden, 
Switzerland and the United Kingdom) and two regional vascular registries (Aust-
ralia and Finland) with somewhat variable input of data (Table 2). The data were 
analysed overall and per country. The main focus was to compare the data from 
the nine countries considering patient demographics, comorbidities, indications, 
operative data, outcome and effectiveness. CAS was not included in the outcome 
analysis. In the outcome analysis, the data were first divided into symptomatic and 
asymptomatic patients.
The data were then further divided into three categories of effectiveness accor-
ding to the published data from randomised studies (Rothwell et al. 2004a; Nay-
lor 2006): 1. highly effective including all symptomatic men with carotid stenosis 
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≥ 50% and symptomatic women ≥75 years of age with carotid artery stenosis ≥ 
50%; 2. moderately effective including symptomatic and asymptomatic women <75 
years of age with stenosis ≥ 50% and asymptomatic men with stenosis ≥ 50%; 3. 
not effective including all patients with stenosis <50% and females ≥ 75 years with 
any asymptomatic stenosis (Table 4). In order to demonstrate the effectiveness, a 
crude number of strokes prevented per 1,000 operations was calculated for each 
group: they were 150, 75 and 0 for groups 1, 2 and 3, respectively. The figures were 
estimated from calculations performed from the pooled analysis of the major RCTs 
(Rothwell et al. 2003; Rothwell and Goldstein 2004; Naylor 2006).
table 3. Carotid procedures included in the Vascunet dataset (IV).
2005 2006 2007 2008 2009-10*
n n n n n total n inv.
data%
Cas% asympt.% Population % pop. 
incl.
australia 528 494 468 543 469 2502 0.0 11.7 33.1 21.5 23.2
denmark 288 334 346 402 459 1829 0.0 0.1 0.0 5.4 100
Finland 144 136 195 237 264 976 0.0 3.3 15.6 5.4 33.5
Hungary 3 1 1 647 656 1407 7.0 3.4 46.1 10.0 78.2
italy 0 0 8137 7559 5653 21349 0.0 17.4 68.6 60.4 100
norway 314 354 370 359 0 1397 0.0 2.9 20.5 4.7 100
sweden 965 1116 1021 1183 1175 5465 0.1 6.8 22.8 9.4 93.4
swizerland 424 453 484 465 0 1826 0.0 0.5 40.4 7.8 100
united 
kingdom
235 2912 2764 4113 6116 16326 1.1 0.6 16.8 62.3 100
total 2901 5800 13786 15508 13263 53077 0.5 8.7 40.1 186.9 83.7
CAS=Carotid artery stenting
* = Includes numbers from year 2010 in the data from Unided Kingdom (1521 CeAs and 
4 CASs) and Hungary (4 CeAs)
Inv. data% = Invalid data, percentage of false inputs that could not be used in the analysis 
(e.g. year irrelevant)
Asympt.% = Proportion of asymtomatic patients
Population = population in millions
% pop. incl. = Percentage of the population included in the registered data
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table 4. Grouping of patients in three effectiveness categories 
group strokes prevented /1000 operations
Patients included 
1 150
Symptomatic men with ≥ 50% stenosis
Symptomatic ≥ 75 year old women with ≥ 50% 
stenosis
2 75
Symtomatic < 75 year old women with ≥ 50% 
stenosis
Asymtomatic men with ≥ 50% stenosis
Asymptomatic < 75 year old women with ≥ 50% 
stenosis
3 0 Any patient with stenosis < 50%Asymptomatic ≥ 75 year old women
Finally, to study the surgical limits of carotid surgery we present a case series of five 
patients operated on with a special midline mandibulotomy technique combined 
with neck incision. The technique was developed by our team of vascular surgeons, 
maxillofacial surgeons and ear, nose and throat specialists. We also reviewed the 
world literature on different surgical techniques that have been suggested in the 
treatment of problems related to the internal carotid artery close to the skull base 
beyond routine carotid exposure.  
stAtisticAl AnAlyses 
In studies I, II and V, simple calculations and estimations were used. In studies 
III and IV, distributions of the continuous variables were studied and tested for 
normality. A univariate comparison between the groups was performed with Stu-
dent’s t test or Mann-Whitney Rank Sum test for continuous variables, and with 
Pearson χ2 test for discrete variables. Two-sided values of P<0.05 were considered 
significant. For multivariate analysis testing associations a model of binary logis-
tic regression analysis including potential confounders as identified by univariate 





estiMAted need And ActuAl provision of effective  
cArotid surgery for stroke prevention (i)
The age structures and population pyramids from the UK, Finland and Egypt 
showed that the Egyptian population is significantly younger, while the aging of 
the population is faster in Finland and UK. The percentage of the population aged 
65 years or older was 16% and 15% for the British and the Finnish populations, 
respectively, but only 4% for the Egyptian population. According to the incidence 
of TIA and stroke and the population data of the three regions, the annual number 
of symptomatic (TIA or stroke) patients with ipsilateral 70–99% ICA stenosis could 
be estimated in each region. According to the estimations, there is a gap between 
the estimated need and actual provision in all three areas. Based on the published 
data, there are at least 1,650 symptomatic patients with severe ICA stenosis who 
would be eligible for effective CEA in Upper Egypt each year, compared with 427 
and 239 patients in Wessex, UK, and Uusimaa, Finland, respectively. Assuming 
that in one year, all 1,650 patients could be found and operated on in Upper Egypt 
with a 6% complication rate, 275 strokes could be prevented (assuming an NNT of 
6). The corresponding figure in the HUCH region is 40 prevented strokes and 71 in 
Wessex. The actual number of CEAs per year was about one half of the estimated 
need in Wessex and Uusimaa but much lower in Upper Egypt.
reliAbility of registered dAtA (ii,iv)
The search engine in HUSVASC provides a possibility to search information with 
several different parameters and to combine them quite liberally. Searching HUS-
VASC for CEAs offered a different result with each preplanned search within the 
same time range (2000 to 2005), showing that different data parameters are not 
equally reliable, and thus none of them should be used alone. The greatest number 
of CEAs (HUSVASC-initial, n = 675) was obtained using these combined criteria 
(Figure 1). Out of these, 518 (71%) were endarterectomies and 118 (23%) were CEAs 
with patch angioplasty of the ICA, while the remaining 39 (6%) were interposition 
grafts from the internal or common carotid arteries, thrombendarterectomy of the 
external or common carotid arteries or incorrectly coded or uncoded operations. 
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ICD-10 Codes PAF 12-14, PAN 12-14 and PAH 12-14 were used in the HILMO 
search to create a dataset that would not miss CEAs even if they were miscoded. 
Figure 1. number of CeAs retrieved from HUSVASC registry in the years 2000–2005 using 
variable search criteria. Different searches yielded different numbers of patients due to 
incomplete data and miscoding. the most comprehensive search used a combination of 
codes, but this also included operations that were not intended to be included (e.g. by-
passes). A = Anatomy, C = operative code (noMeSCo), I = Indication. (II)
Cross-matching these initial results from the two datasets (681 in HILMO against 
675 in HUSVASC) showed that 640 CEAs were registered in both; 35 were only 
included in HUSVASC, while 41 were only recorded in HILMO (Figure 2). To deter-
mine the reasons for missing these ‘‘assumed’’ CEAs from HUSVASC, we checked 
the patient records. Out of the 41 operations, 12 (29%) were not CEA operations, 
10 (24%) were registered but without any medical data, 6 (15%) were entirely un-
registered, 6 (15%) were missing some key data such as anatomy or the indication 
for the operation, 2 (5%) had incorrect operative codes, and in the remaining 5 
cases we could not identify any reason. 
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Figure 2. Comparison of the initial searches showed that 640 patients were included in the 
search from both datasets. 41 were only included in HILMo and 35 only in Husvasc (II).
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Figure 2. Compa ison of the ini i l searches showed that 640 patie ts were inclu ed in the search from both 
datasets. 41 were only included in HILMO and 35 only in Husvasc (II). 
 
When the operative codes PAF14 and PAN14, which are the two most specific codes for CEA, 
were used, the majority of the initial CEA results in both datasets were included (94% for 
HUSVASC and 90% for HILMO). Cross-matching the 636 operations coded as PAF14 or PAN14 
in HUSVASC (HUSVASC codes) against the corresponding 614 in HILMO (HILMO codes) 
showed that 592 operations were available in both sets: 44 only in HUSVASC and 22 only in 
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When the operative codes PAF14 and PAN14, which are the two most specific 
codes for CEA, were used, the majority of the initial CEA results in both datasets 
were included (94% for HUSVASC and 90% for HILMO). Cross-matching the 636 
operations c ded as PAF14 or PAN14 in HUSVASC (HUSVASC codes) against the 
corresponding 614 in HILMO (HILMO codes) showed that 592 operations were 
available in both sets: 44 only in HUSVASC and 22 only in HILMO (Figure 3).
Figure 3. Multilevel cross-matching based on individual personal identity codes revealed sev-




Figure 3. Multilevel cross-matching based on individual personal identity codes revealed several problems in 














According to the final dataset, the perioperative mortality, morbidity, and combined 
morbidity and mortality rates were 0.5%, 2.2%, and 2.7%, respectively. Stratification of these 
results by indication for surgery showed that stroke patients had the highest rates of 
morbidity and combined morbidity and mortality (3.2% and 3.9%, respectively). The rates for 
TIA patients (both 1.8%) and amaurosis fugax patients (morbidity and combined morbidity 
and mortality rates of 1.8% and 2.3%, respectively) were lower. None of the asymptomatic 
patients suffered a perioperative stroke or death. Furthermore, both registries, irrespective of 
the completeness of the data, provided comparable rates of morbidity and combined 
morbidity and mortality. Yet, stratification of these rates according to the indication of 
operation showed greater differences between datasets, particularly for stroke rates. A search 
using codes for postoperative central nervous system complications available in the ICD 
coding systems (ICD-9 code 997.x and ICD-10 codesY65, Y69, Y83, and Y88.x) in the entire 
registry of HUCH yielded 38 patients, but none of them had undergone CEA.  
 
Delay and patient referral pathways in Helsinki and Uusimaa. (III) 
 
As planned, 100 consecutive symptomatic CEA patients were identified. During the same time 
period, 42 asymptomatic patients were operated (26.9%), and 10 symptomatic patients were 
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According to the final dataset, the perioperative mortality, morbidity, and combined 
morbidity and mortality rates were 0.5%, 2.2%, and 2.7%, respectively. Stratifi-
cation of these results by indication for surgery showed that stroke patients had 
the highest rates of morbidity and combined morbidity and mortality (3.2% and 
3.9%, respectively). The rates for TIA patients (both 1.8%) and amaurosis fugax 
patients (morbidity and combined morbidity and mortality rates of 1.8% and 2.3%, 
respectively) were lower. None of the asymptomatic patients suffered a periopera-
tive stroke or death. Furthermore, both registries, irrespective of the completeness 
of the data, provided comparable rates of morbidity and combined morbidity and 
mortality. Yet, stratification of these rates according to the indication of operation 
showed greater differences between datasets, particularly for stroke rates. A search 
using codes for postoperative central nervous system complications available in 
the ICD coding systems (ICD-9 code 997.x and ICD-10 codesY65, Y69, Y83, and 
Y88.x) in the entire registry of HUCH yielded 38 patients, but none of them had 
undergone CEA. 
delAy And pAtient referrAl pAthWAys in helsinki  
And uusiMAA (iii)
As planned, 100 consecutive symptomatic CEA patients were identified. During 
the same time period, 42 asymptomatic patients were operated (26.9%), and 10 
symptomatic patients were treated with CAS, but they were excluded from the 
analysis.  The first contact with a health care professional is presented in Table 5.
table 5. the first health care professional contact of the 100 patients operated in HUCH (III).
First health care system contact (n)
Health care centre 43





neurologist outside HUCH 5
Surgical ward 4
Pain clinic 1
Thirty-two percent of the patients were operated within 4 weeks and eleven per-
cent within two weeks of their presenting symptom. It was more likely that CEA 
was performed within two weeks if an emergent consultation to the tertiary clinic 
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hospital neurologist on-call took place (OR 12.6, 95% CI 1.5–104, p=0.019).  The 
same was true for having the operation within one month with an OR of 6.1 (95%CI 
2.4–15.8; p<0.0001). Overall, about a half of the patients had emergency consulta-
tion or referral (47.0%; 47/100).
The median time from the index symptom to surgery was 47 days (3–688 d). 
The total delay was significantly shorter if the index symptom was a minor stroke 
with a median of 34 d, (range 7–216 d) or a major stroke (median 22 d; range 8–102 
d) compared to amaurosis fugax (median 66 d; range 9–688 d) or TIA (median 69 
d; range 3–216 d) (p<0.005, Kruskall-Wallis).
If the vascular surgeon was consulted during the first visit, the median total 
delay was 25 d (range 3–148 d) versus 84 days when the vascular surgeon was not 
consulted (range 10–688 d; p<0.0001). Moreover, if the carotid examinations were 
performed during the first hospitalisation, the total delay was significantly shorter 
compared to elective carotid artery examinations: median 29 d (range 5–148 d) 
vs. 89 d (range 21–688 d); p<0.0001.
During the delay from the first symptom to surgery, 10 (10%) patients had re-
currence or progression in their symptoms, i.e. recurrent TIA (n=2), progression 
of TIA to minor stroke (n=2), progression of minor stroke symptoms (n=2), prog-
ression of symptoms from minor to major stroke (n=2) or progression of major 
stroke (n=2). All these patients underwent CEA, and the median (range) total delay 
from symptom to surgery for these patients was 8.5 (1–30) days. When compared 
to the data of the subgroup analysis from the randomised studies (Naylor 2006), 
62 (62%) of the patients were operated with a good benefit expectation (NNT<7), 
19 (19%) with a reasonable benefit expectation (NNT 8–20) and 19 (19%) were 
operated too late (Table 6).
table 6. All 100 CeA patients grouped according to their sex, severity of stenosis and time 
to surgery from index symptom, and the respective theoretical number needed to treat 
derived from the nASCet and eCSt subgroup data6,9. the colours represent different nnt 
groups. Green: nnt < 7 equivalent to best possible benefit; Yellow: nnt = 8–20 equals to 
reasonable benefit; red: operation theoretically harmful for the patient (i.e. nnt cannot be 
calculated). the number represents the number of patients in each group. (III)
degree of 
stenosis / gender
0-2 weeks 2-4 weeks 4-12 weeks > 12weeks
70-99% male 8 11 19 16
70-99% female 3 4 10 6
50-69% male 0 5 7 8
50-69% female 0 1 2 0
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There were 2 perioperative major strokes and 1 minor stroke. These operations took 
place 9 and 52 days from the index symptom, respectively. One further patient, oper-
ated 102 days from a TIA, died on the 4th postoperative day. She had postoperative 
headache, a generalised seizure and high blood pressure postoperatively, but the 
transcranial Doppler (TCD) finding and clinical picture were otherwise untypical 
for hyperperfusion syndrome. In autopsy, the cause of death was cerebral anoxia, 
and the operated area was smooth with no residual flaps. Moreover, there was 1 
hyperperfusion syndrome, 1 TIA and 3 cranial nerve injuries. Taken together, the 
rate of disabling stroke and mortality was 3/100 (3%) and the rate of any stroke 
or death 4/100 (4%).
internAtionAl registry dAtA coMpAring effectiveness 
of ceA in nine countries (iv)
Of the 53,077 carotid procedures, 48,185 were CEAs, 4,602 were CASs and 290 
were invalid data with unrelated years recorded, i.e. false data input. Finland and 
Australia presented regional register data covering 33.5% and 23.2% of the to-
tal population, respectively. The other countries presented national data with a 
78.5–100% coverage.  
table 7. effectiveness of carotid provision in the whole study population, based on the 
effectiveness categories defined in table 4. Utility rates of carotid territory intervention 
(CAS+CeA) in one year. Year 2008 was chosen because it represented the most compre-
hensive data from all countries (IV).
sPrev/1000 Peff % sympt % 2008 n utility rate utility s
australia 106 81.4 66.9 543 10.9 7.3
denmark 131 100 100 402 7.4 7.4
Finland 120 91.6 84.4 237 13.2 11.1
Hungary 87 66.7 53.9 647 8.3 4.7
italy 73 55.7 31.4 7559 12.5 3.9
norway 116 88.7 79.5 359 7.7 6.1
sweden 117 89.5 77.2 1183 13.5 10.4
switzerland 102 78.1 59.6 465 6.0 3.6
united kingdom 118 90.4 83.2 4113 6.6 5.5
total (n or average) 100 76.5 70.7 15508 9.6 6.7
SPrev / 1000 = estimated number of strokes prevented in 5 year follow-up by performing 1000 CeAs 
Peff % = Proportional effectiveness, the most effective country 
(Denmark) used as a reference
Sympt % = Proportion of symptomatic patients
2008 n = number of operations in 2008
Utility rate = number of carotid interventions / 100,000 inhabitants in 2008
Utility S = number of carotid interventions for symptomatic disease / 100,000 inhabitants in 2008
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Each patient was categorised into a theoretical effectiveness category according 
to Table 4. Based on this assumption, different values for comparison could be 
calculated. The numbers of strokes prevented per 1,000 operations (in the 5 year 
follow-up) was 131 in Denmark and 73 in Italy; it can therefore be estimated that 
with these assumptions, the CEA provision in Italy reaches 56% of the effectiveness 
in Denmark (Table 7 and Figure 4).
The utility rate of the representative year 2008 gave 6.0 to 13.5 operations per 
100,000 inhabitants in the included area, the lowest in Switzerland and the highest 
in Sweden. If symptomatic patients had only been operated, the corresponding utility 
rate would have varied between 3.6 in Switzerland and 11.1 in Finland (Table 7).
The combined mortality and stroke figures show that CEA for asymptomatic 
lesions was safer in all countries apart from Finland. However, the small difference 
in Finland is not significant. The reported complication figures stratified by symp-
tom and admission mode are presented in Table 8.
Figure 4. the proportional effectiveness of carotid provision divided into three levels for 
each country. 
1. (HIGHLY eFFeCtIVe): ≥50% stenosis in symptomatic men, ≥50% stenosis in 
symptomatic females ≥75 years old
2. (MoDerAteLY eFFeCtIVe): ≥50% stenosis in asymptomatic men, ≥50% stenosis in 
symptomatic and asymptomatic females < 75 years old
3. (MILDLY or not eFFeCtIVe): <50% stenosis, asymptomatic stenosis in females ≥75 
years



















table 8. Death and/or stroke rate in asymptomatic and symptomatic carotid endarterectomy 
patients (IV).
asymptomatic symptomatic
 m+m % m+m % emergency elective
australia 0.9 2.1 3.1 1.5
denmark n.a. 3.7 6.0 3.6
Finland 2.0 1.9 3.0 1.8
Hungary 2.1 3.4 4.1 3.3
italy 0.5 0.9 3.8 0.7
norway 2.5 3.8 7.0 3.6
sweden 2.7 3.0 3.5 2.5
switzerland 1.6 3.4 D.m. D.m.
united kingdom 1.8 2.4 3.6 2.3
total 1.0 2.4 3.6 2.1
M+M = Morbidity and mortality, i.e. combined stroke and death
D.m. = data missing
The binary logistic regression model included all 53,077 cases. The symptomatic 
patients had a higher risk of stroke or death than asymptomatic patients (OR 1.37, 
95% CI 1.14–1.63, p=0.001). CAS was more dangerous than CEA (OR 1.78, 95% 
CI 1.36–2.33, p=0.000), and emergency operations had more complications than 
the elective ones (OR 2.04, 95% CI 1.68–2.49, p= 0.000). From the whole mate-
rial, not taking into account the proportion of different indications (symptomatic 
or asymptomatic), the theoretical effectiveness or the reliability of the inclusion of 
complications, it seemed safest to undergo CEA in Italy and most dangerous in 
Norway with OR of 0.26 (95% CI 0.21–0.33, p= 0.000) and 2.02 (95% CI 1.49–2.72, 
p = 0.000) respectively. The United Kingdom was used as a reference.
extensive cArotid surgery And Midline MAndibulotoMy (v)
Five patients were operated on using combined midline mandibulotomy and ex-
tended neck incision for medial carotid exposure. Two patients had high internal 
carotid aneurysms extending close to the skull base. Three patients had a neoplastic 
lesion: 2 malignant oral tumours with neck metastasis and 1 primary paraganglioma. 
All operations were initially successful, and no immediate strokes or deaths were 
encountered. One aneurysm patient and the paraganglioma patient had almost no 
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disease or operation-related morbidity at follow-up. One patient with an extended 
lingual epidermoid carcinoma with local extension into the mandibular bone was 
recurrence-free at 3.6 years. One aneurysm patient with glossopharyngeal nerve 
injury died 30 days postoperatively due to aspiration pneumonia. Another patient 
died due to malignant tumour recurrence after 15 months. Hypoglossal and glos-
sopharyngeal nerve injury was also seen in the patient with a paraganglioma invad-
ing the glossopharyngeal nerve close to the cranial base, but the patient recovered 
and returned to his previous activities. The vagal nerve was resected in all three 
tumour cases with minimal morbidity. The external carotid artery was reconstructed 
end-to-side with the interposition graft in two cases and ligated in three cases. 
Median operation time and blood loss were 550 minutes (148–705 minutes) and 
1,730 mL (1,000-3,500 mL), respectively. A Pruitt-Inahara shunt was used in 3 
patients with carotid closure time of 8–11 minutes. The carotid closure time was 
15 and 31 minutes in the aneurysm operations in which no shunt was used due to 




1. knoWing WhAt should be done (evidence)
It is not common in surgery to perform potentially dangerous operations of pre-
ventive nature which do not bring immediate benefits to the patient. However, in 
carotid surgery, it is easy to find scientific evidence on which to rely in surgical 
decision-making. In addition to the large randomised studies, an enormous number 
of studies of differing quality have been conducted on carotid surgery. A simple 
PubMed search with the words “carotid AND surgery” yields almost 36,000 hits. 
If one spent 10 minutes on every article, it would take 250 days of uninterrupted 
reading to go through all of them. Moreover, the word “stroke” yields over 160,000 
publications, and it would clearly be an impossible task to go through all of these. 
Luckily, the number of important studies is much smaller, although still large. A 
fair number of international, national and local guidelines have been published, and 
although they are based on the same studies, there are still major variations in the 
interpretation of the studies. Even more variation seems to exist in the interpretation 
of these guidelines. This is due to the fact that, ultimately, treatment decisions are 
made between individual surgeons and patients, and there are many non-scientific 
details, which have not been evaluated in randomised trials, but which also affect 
decision-making. The fear of stroke makes the patients quite prone to accept the 
advice given by the treating physician.
In order to make full use of the stroke preventive potential of CEA, continuous 
efforts to improve the effectiveness, coverage and safety of the practice are needed. 
An optimal system would identify, catch and treat all the patients whose strokes are 
preventable, but the reality remains far from this idealistic situation. 
We estimated an optimal theoretical number of CEA provision by using exis-
ting incidence figures of TIA, minor stroke and age structure of three regions and 
compared them with the actual provision in these regions: two from public-based 
health care systems of developed countries with a supposedly well-functioning 
process, and one from a developing country, where the medical registry was still 
being improved. None of the systems was optimal. About a half of the patients that 
should have been operated on were missed both in Finland and the UK, while a 
much lower proportion of patients had surgery in Egypt. The estimations include 
an assumption that the actual CEA patients were patients who should be operated 
on in an optimal situation. It is clear that none of the regions could present an 
optimal practice, and it is therefore probable that the figures in the comparison, 
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ineffective as they seem, still give too positive a picture of the real situation. As a 
certain amount of ineffectiveness is always inevitable, the numbers used in planning 
the service should be higher than the ones in our calculations.
The delay from the first symptom to surgery has been identified as a major source 
of ineffectiveness. The two- or even one-week target, which is now recommended in 
guidelines, may actually be too long because after a TIA most of the strokes occur 
in a shorter period of time (Rothwell et al. 2006, Naylor 2008). Reorganising the 
patient pathways is an inexpensive way to increase effectiveness. However, there 
are several rate-limiting steps that must be identified, many of which are common 
to different areas, but there are also a lot of problems that should be addressed 
locally. The knowledge gained from how to make the administration of thrombo-
lysis faster in ischaemic stroke could be used in order to cut down the “symptom 
to knife” time (SKT). 
In Scotland, only 51% of 813 patients referred to a TIA clinic were diagnosed as 
having a TIA (Murray et al. 2007). In order to evaluate which patients should be 
guided to the fast lane in clinical practice, recognition and stratification tools have 
been developed. The ABCD2 score, extended recently with infarction, (ABCD2I) 
provides validated tools to identify a high risk of stroke after TIA in order to prio-
ritise their urgent assessment and treatment (Table 9) (Johnston et al. 2007; Giles 
et al. 2010). ABCD2 has also been proven to estimate the risk of recurrent stroke 
severity (Chandratheva et al. 2010). The Face, Arm, Speech Test (FAST) has been 
used in telephone assessment by emergency call centre and paramedic triage to 
make stroke thrombolysis possible, so that correct patients could be identified and 
immediately transported to emergency room consultation (Harbison et al. 2003; 
Mohd Nor et al. 2004) and an evaluation for thrombolysis.
table 9. the ABCD2 score to estimate an early risk of stroke after tIA and the severity of 
stroke.
the patient has a high risk of stroke if the total score is four or higher. 
(Johnston et al. 2007; Giles et al. 2010)
Feature Points
Age > 60 1
Blood pressure >140/90 1
Clinical features
  - Speech disturbance




  - ≥10 min






In many clinical situations, it can be justified to perform CEA in a less effective 
situation. If the safety of the operation is locally better than in the randomised 
studies, patients with a lower risk of stroke, moderate grade stenosis or even asymp-
tomatic patients may be candidates for CEA. Some patients are willing to take the 
additional risk of surgery with lower expectations for benefit just to eliminate the 
idea of having a stenotic carotid artery with a risk of stroke or death in the future. 
The treating physicians bear the responsibility of being aware and sharing with 
the patients the information on the benefits and hazards of this preventive surgery 
in different clinical situations. Without knowledge of personal and local results, it 
remains impossible to give this advice objectively. Despite the abundance of infor-
mation, there is a continuous need for high quality trials that give more tools both 
to surgeons and health care providers. 
2. knoWing WhAt hAs been done (outcoMe AnAlysis)
Continuous critical evaluation of the process and knowledge of the results (outcome 
analysis) offer an opportunity to improve the process and to prevent more strokes. 
Clinical registries provide an opportunity to assess the process and outcome 
locally and to make comparisons over time and with other published data. A re-
gister can provide benchmark indicators for the assessment of treatment and its 
cost-effectiveness, but the original indicators have not been planned in an optimal 
way, and changes in register setup may be necessary (e.g. delay times may be needed 
to be included in the registry data). One advantage of registered data is the great 
number of procedures which can be analysed. Moreover, patients that would not be 
included in prospective randomised trials are included, a fact that makes the data 
more scattered but also more comprehensive. A major concern in using registered 
data is data validity. It is typical that a registry seems reliable until it is possible 
to compare it against another register. After cross-matching the registries, several 
sources of error may be identified and corrected. In Finland, as in most developed 
countries, several independent registries are kept for health care monitoring purpo-
ses (Mähönen et al. 1997; Mähönen et al. 2000; Lepäntalo et al. 2008; Meretoja et 
al. 2010b). Data of every operated patient are included in several registries, but these 
registries are not automatically cross-matched. The input process is of key value to 
the register and should be monitored and audited regularly. For instance, if there 
are major systematic errors in coding, the value of the registry can be questioned 
(“garbage in – garbage out”). Without any knowledge about the missing patients, 
which is a cause of error in registries, it is dangerous to make definite conclusions. 
On the other hand, the registry is of no use if the systems of data extraction and 
analysis are not effective. Legislation and data privacy issues may also be obstac-
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les to comprehensive registries, as has been the case with Finnvasc and Karbase 
(Lepäntalo et al. 1994; Kantonen 1997).
It is possible to use various search criteria for clinical registries such as the 
HUSVASC dataset. This makes it possible to use the data in various ways, but it 
also introduces problems in the validity of the search results. If all CEAs are to be 
included, a combined search should be used to minimise the likelihood of including 
unrelated operations. If the search does not include any extra patients, some pa-
tients will inevitably be missed in the search. On the other hand, if a more simple 
code-based dataset like the HDR is used, there will be limitations in the possible 
searches. If a single dataset is retrieved, erroneously coded patients will be missed 
in the search, and they cannot be retrieved in the future. Moreover, the final search 
results may include miscoded patients.
We have shown several problems in cross-matching two different registries of 
HUCH on an individual patient level and came to the conclusion that a simple 
search, which seems logical, may in fact include many invisible errors. Despite 
these problems, we found that there were no major systematic differences between 
the two registries that were compared in the present study. If 90% of the patients 
are included, the coverage can be considered acceptable. The coverage in both our 
local registries was good, and the data compared well with the previously publis-
hed figures from other countries. The perioperative morbidity and mortality rates 
after CEA compared favourably with the results of major randomised trials and 
systematic reviews or meta-analyses. We did not identify systematic exclusion of 
patients with poor outcome, and thus either of our local registries can be used for 
the identification of true complication rates. The specific vascular registry allowed a 
more detailed analysis according to indication for surgery. We also found that pos-
toperative complication codes of ICD-9 or ICD-10 coding systems were not used for 
carotid complications at our hospital. Accordingly, uncritical data utilisation would 
lead to severe miscalculations. This emphasises the importance of scrutinising re-
gistry data and maintaining quality control by conducting occasional random data 
sample audits as has been previously suggested (Meretoja et al. 2010b).
3. knoWing WhAt others do better (benchMArking)
It is not fruitful to boast about one’s excellent results; instead, one should try to 
understand what one could do better. Moreover, from the perspective of quality 
improvement, it is not at all rewarding to know if CEA is performed badly somewhere 
else. Benchmarking means learning from superior performance. It is impossible 
to compare CEA effectiveness between regions without knowing the quality of the 
background data and regional reporting standards. Vascunet has taken the first 
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steps towards real European country-wise comparisons in vascular surgery. The 
problems in comparing two local registries are far less complicated than compar-
ing the results from different countries. Cultural differences, differences in health 
care provision, differences in population, health economics, data reliability and 
data input and analysis may hide many important sources of error. Nevertheless, 
it is informative to compare the available data and to identify questions for future 
research. The differences between countries may reveal previously unidentified local 
problems and provide tools to abolish them and to improve patient care. Datasets like 
Vascunet will also give more specific benchmark tools. The Vascunet registry should 
include efforts to standardise the reporting of essential parameters. Gradually, with 
both repetitive reporting and focused audits, a minimum necessary dataset can be 
defined. This minimum dataset should also include parameters for STK calcula-
tions. When it comes to delay, it is interesting to know what solutions others have 
detected in their efforts to expedite the process. In the near future, it is important 
that registries should provide reliable delay times regionally, and thus provide a 
solid foundation for improving the system, including proper resource allocation.
4. knoWing WhAt chAnges should be done  
(AnAlysis And benchMArking)
Several suboptimal details in treatment solutions and processes exist. Delay before 
CEA has been identified as a major risk factor for stroke after TIA or stroke. When 
evaluating the effectiveness of the process, shortening the delay would be one of 
the most effective methods to improve performance. It is far more important than 
deciding whether to use general or local anaesthesia, CEA or CAS, or the use of 
patch, which all have been subject to extensive research among other treatment 
details. On the other hand, no studies have been, or are likely to be, executed in 
which patient randomisation is based on the timing of surgery. Accordingly, most 
information is based on post hoc analyses of randomised trials and historical data. 
A large body of nonrandomised evidence support the fact that TIA and minor 
stroke patients should be treated urgently and that more 24-hour TIA service clinics 
should be developed (Johnston et al. 2006; Giles and Rothwell 2007; Lavallee et 
al. 2007). The introduction of a centralised system is ineffective if patients remain 
unaware of when and where to seek help. Physician awareness is also an obstacle 
to the optimisation of patient referral pathways (Hirsch et al. 2001).
Vascular and stroke registers should monitor the delay from symptom to sur-
gery online. This way, it will be possible to identify and address the problem areas 
and problems in the work-up process. The importance of proper medication in 
stroke prevention is also crucial. Many series show that patients’ medication has 
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a tendency to get worse when some time has passed from a study (Johnson et al. 
2007). However, recent data suggest that more and more patients are on optimal 
or almost optimal medication at the time of TIA or stroke, and thus there may not 
be much to improve in terms of conservative treatment in a well-organised stroke 
service (Sairanen et al. 2011).
5. perforMing these chAnges  
(iMpleMentAtion of iMproveMents)
After understanding the need for change, new methods should be developed and 
implemented. It is often labour- and/or cost-intensive to change the old traditions 
in health care. On the other hand, some quite simple changes may have a major 
effect on outcome. For example, from the point of view of costs, it is irrelevant 
whether a patient is operated within two weeks or within one month, provided that 
the number of patients and the complication rates remain the same. However, lo-
cally at HUCH we saw an 80% increase of CEA operations after implementing the 
fast-track pathway, and surgery is also performed earlier after TIA or minor stroke 
(Figure 6.). It is impossible to identify the exact reasons for this, but there have 
certainly been some improvements in diagnostics and referral pathways, including 
imaging work-up and the consultation of vascular surgeon already at the neurologi-
cal emergency room. However, if there is no positive feedback, this increase may 
be transitional when the initial enthusiasm wanes. Therefore, one should be aware 
of these major volume changes as soon as possible; otherwise, the whole process 
may self-destruct in the expansion. Online monitoring and reporting, at least on a 
yearly basis, provide information about the process for further improvements and 
decision-making. 
Most often, the identified problems are not the only ones that should be addres-
sed. In modern hospital environment, several specialities have their own interests, 
and these may collide with the changes at hand. For example, it may be difficult to 
find the increased table time for early surgery and emergency imaging capacity. Close 
collaboration over specialist boundaries is essential in a high-quality process of care. 
It is impossible to implement an effective CEA practice without close collaboration 
amongst all health care professionals from the first patient contact to follow-up. 
Disease-specific centralisation makes the referral and consultation patterns simple 
and more effective. A matter that is very difficult to investigate, but is clearly seen 
in daily practice, is the importance of personal contact between treating physicians. 
However, standardised order templates along with register monitoring have been 
shown to have an impact on patient care improvements (California Acute Stroke 
Pilot Registry (CASPR) Investigators 2005; The AGREE Collaborative Group 2003).
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The whole process of care should be planned in a way that supports fast lane 
diagnostics and treatment. If the target of cutting down the delay from several 
weeks to one week, and then to 48 hours or faster, is to be reached, then it will 
also be vital that neurologists and vascular surgeons should physically work in the 
proximity of each other with adequate resources. Regional education of patients 
via mass media and primary health care personnel, neurologists, vascular surgeons 
and all professionals in contact with these patients is key to success. It should also 
include the fast-lane way of thinking. 
6. knoWing if the chAnges perforMed Were effective 
(reAnAlysis)
During outcome analysis and benchmarking, the chosen indicators are tested, and 
novel quality indicators for analysis can be identified.  After the implementation 
of changes, their success should be subjected to reanalysis, where the informa-
tion gained from the previous baseline measurements will be compared with data 
from the updated system to find out if the targets have been reached. During the 
process, new instruments detected can be used to further improve the quality of 
the analysis. This reanalysis should be an ongoing audit, which is made possible 
by continuous registry follow-up (Mehta et al. 2002; CASPR Investigators 2005; 
Lepäntalo et al. 2008).
It is obvious that data on CEAs performed within, say, 48 hours of the symptoms 
are still scarce. It seems safe to cut down the SKT to one or two weeks (Salem et 
al. 2011), but surgery for stroke in evolution or crescendo TIA carries a higher risk 
(Rerkasem and Rothwell 2009 a). When the delay is shortened to a minimum, the 
boundary between these different entities gets diluted.
The fact that a study on process structure is performed and its results are criti-
cally analysed will inevitably have an effect on the local process of care. This is also 
one of the reasons why a retrospective method was chosen when planning the study 
on the delay of carotid surgery. The delay had been identified earlier as one of the 
main problems in effective CEA provision, but a TIA acute service, that is, a TIA 
clinic, and extra operation table time was introduced during the study period. This 
may be seen as an increase in the number of operations in our region (Figure 6.). 
It is also noteworthy that the proportion of asymptomatic patients did not increase 
during 2009 and 2010 when the study was actually performed, suggesting that the 
increase that has been witnessed is a true reflection of the efforts in streamlining the 
process of care for those with a high risk of stroke. It is difficult or even impossible 
to know the exact reasons for changes in patient volume. However, the increase 
seen after 2007 is quite clear and it cannot be explained with aging population, 
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for example. At the same time, a TIA clinic was introduced, but larger numbers of 
patients were not guided to this practice until late 2010, and it does not seem to 
explain the increase. However, having a media campaign for laypeople and edu-
cating the physicians in health care centres may have had an effect. There was no 
clear policy change on the emergency admittance of patients. The study was planned 
because we suspected that the delay was longer than the 2 weeks recommended in 
the national and international guidelines, which indeed turned out to be the case. 
We think that it is important to continue the online monitoring of patient flow. 
Resources should be allocated to this kind of monitoring, and the collaboration 
between vascular surgeons and neurologists must remain active.













(III)Publication of pooled analysis
(Rothwell et al. 2003)
ACST publication
(ACST collaborative group 2004)
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7. respectfully pushing the liMitAtions of  
conventionAl thinking (innovAtion And developMent)
As more operations are performed within hours or few days of the symptoms, new 
situations will be encountered. More patients will present with floating thrombus 
and residual thrombus in intracranial arteries. The right approach to these situ-
ations remains to be defined, but based on the present data, it seems justified to 
operate despite fresh thrombus at the bifurcation (Bhatti et al. 2007; Paty et al. 
2003; Weis-Müller et al. 2008); however, the operation should perhaps be post-
poned when intracranial thrombus is seen. More acute occlusions of the arteries 
will also be seen, but the scientific basis on how to deal with these situations is far 
less solid than for CEA in most other situations. Promising techniques, such as 
intraluminal thrombolysis and mechanical thrombectomy, are becoming routine 
practice, but they are also typically techniques that should be performed within 
close scientific surveillance, and initially practiced with criticism until evidence from 
RCTs is available (Baker et al. 2011). In order to achieve continuous improvement 
in the treatment of these patients close co-operation between vascular surgeons, 
angioradiologists and neurologists on-call should be available. This kind of service 
cannot be organised without close 24-hour proximity.
Other reasons for the surgical approach to carotid arteries are not as common 
as CEA for stroke prevention. Nevertheless, routine CEA gives surgical experience 
that may also be used in tumour or aneurysm surgery. Traditionally, radical neck 
surgery comprises radical tumour resection and lymph node dissection. Carotid 
interposition facilitates more radical surgery in situations where radical excision 
would otherwise not be possible (McCready et al. 1989; Wright et al. 1996; Muhm 
et al. 2002; Longo and Kibbe 2005). Head and neck surgeons have routinely use 
mandibulotomies for the better exposition of the oropharynx (Shaha 1991; Dubner 
and Spiro 1991; Amin et al. 1999). Combining the experience of different surgical 
specialists can lead to novel methods of treatment, which would otherwise not be 
possible, as has also been demonstrated by the innovative team in Marseille (Rosset 
et al. 2000; Malikov et al. 2010). It is important, however, to identify and accept 
the limitations of the new techniques introduced. The caseload per surgeon and 
institution will remain low, and there are clear reasons to centralise these opera-




The full unused potential of stroke prevention by CEA remains to be effectively 
utilised. Administrative changes in early diagnostics and patient referral path-
ways making urgent CEA possible would prevent far more strokes than chang-
ing small details in the perioperative process itself. The registered data in the 
HUCH region seem to have reasonable validity and thus give reliable feedback 
to the treating physicians and information for resource allocation and process 
planning purposes. The results of the randomised clinical trials provide a solid 
base for individual treatment planning although the trials do not cover all situ-
ations faced at daily practice. Monitoring the results and delay and their report-
ing should be comprehensive, and the feedback systems should give immediate 
information for the physicians treating these patients. This information should 
also be used in resource allocation and regional education on all levels of health 
care. There are major differences in the effectiveness of the treatment process 
in different countries. A comparison with other countries should lead both the 
treating physicians and the decision-makers to critically evaluate and improve 
their own system. 
Standard surgery of the internal carotid artery may be extended to the base of 
the skull in tumour or aneurysm surgery when there is no other option, but the 
surgeons should be aware of several options and potential complications. This 
kind of surgery remains rare and should be centralised to specialised clinics in 
order to increase the caseload and experience of the treating multidisciplinary 
team of physicians.




This study was carried out at the Department of Vascular Surgery of Helsinki Uni-
versity Central Hospital in 2005-2011.
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